Wharton

MBA Program in Health Care Management

2014 RESUME BOOK Contents

Program Description ...... 4 Curriculum ...... 5 Graduates ...... 6-28 Internship Sponsors ...... 29 Health Care Program Mentors ...... 30-33 Administration ...... 33 Faculty ...... 34-35

Thank you for your interest in the Wharton MBA Program in Health Care Management . For further information, resumes, and appointments, contact:

June Kinney, Associate Director, MBA Program in Health Care Management The Wharton School University of Pennsylvania 3641 Locust Walk Philadelphia, PA 19104-6218

215 .898 .6861 | Fax 215 .573 2157. email: aleszczc@wharton .upenn edu.

For information on the Wharton Health Care Management Alumni Association, visit www .whartonhealthcare .org

For detailed information on the Health Care Management Department educational programs, visit http://hcmg .wharton upenn. edu/. 2014 Health Care Management

M .B .A . Graduates The University of Pennsylvania was founded by Benjamin Franklin in 1740 . Although the University carries the name of the Commonwealth, it is not a state university but an independent, private, nonsectarian institution . As one of the country’s earliest educational institutions, it has consistently initiated advances in teaching and research and has steadily generated specialized fields of higher education . Penn, as the University is commonly known, was the first American university to form departments of botany, hygiene and public health, surgical research, and research medicine . The University School of Medicine, formed in 1765, was the first in North America, as was the teaching hospital founded in 1874 . The world’s first psychological clinic was opened at Penn in 1896 .

The Wharton School, in the same spirit of innovation and excellence, was the world’s first collegiate school of business and management . Founded in 1881 with a gift from Joseph Wharton, the Philadelphia industrialist and philanthropist, the Wharton School undertook the pioneer steps in elevating training for business significantly above its previous level as noncollegiate commer- cial education . In 1921, the formation of the Graduate Program signaled the advancement of business administration at Wharton to the highest levels of professional education .

Today, the Wharton School has more than 270 faculty members teaching in both the graduate and undergraduate divisions and conducting a continually expanding volume of research . The 1,600 students in the master’s degree program may choose from among more than 200 courses and over 18 majors and concentrations, a variety reflecting the fact that the Wharton education complements the career goals of the individual .

This brochure is provided to introduce you to the 2014 Wharton Health Care Management Program graduates .

We encourage you to consider these individuals for employment .

3 Program Description

The Graduate Program in Health Care The Leonard Davis Institute of Health Economics Management is a full-time two-year MBA (LDI) is an interdisciplinary center for research curriculum offered by the Health Care Manage- and education in the organization, financing, ment Department of the Wharton School . The and delivery of health care . Through LDI, University program, the principal educational effort at the of Pennsylvania faculty and staff work together Leonard Davis Institute of Health Economics, is on issues concerning health policy, health designed to provide managerial and technical insurance, managed care, hospitals, corporations, expertise to students interested in the health pharmaceutical companies, and other health- care management field . By combining the skills related organizations . Established in 1967, the of the Wharton disciplines with sensitivity to the Institute appropriately bears the name of the late needs of health care providers and recipients, the Leonard Davis, one of the foremost innovators in Wharton MBA health care graduate can effectively private health insurance in the United States . He manage the delivery of health services and was the founder of Colonial Penn Group, Inc ,. a products at all levels . company that has pioneered in insurance for older Americans . Both Mr . Davis and Mrs . Sophie Davis The Program has produced graduates who have were generous benefactors to the University of chosen careers in hospitals and other medical Pennsylvania, contributing basic support for the institutions, pharmaceutical, biotechnology and activities of the Leonard Davis Institute . medical device companies, financial services, entrepreneurial ventures, consulting firms, insurance firms, private health industry, and federal, state, and local government . Many of these MBA graduates now hold positions as chief executive officers, directors, and other key decision makers in health care organizations .

4 Curriculum The Wharton Management Core

All students are required to complete the Wharton Manage- Global Immersion Program ment Core . The Wharton School’s core curriculum is designed The Wharton Global Immersion Program is an optional to increase crossfunctional integration, extend global experi- half-credit elective course that provides first-year students ence, strengthen leadership training, and introduce new with an in-depth exposure to international business courses on key management issues . The core curriculum practices and first-hand insights into a foreign culture . provides groundwork in basic management disciplines: economics, finance, financial and cost accounting, manage- The Health Care Major Courses and Electives ment science, managing people and organizational design, These courses promote an understanding of concepts, marketing, operations management, the governmental and institutions, and issues involved in the organization, legal environment of business, statistics, and strategy . financing, and delivery of health services and products in the United States . Health care electives are selected Fixed Core: consistent with individual career objectives and interests . • Foundations of Teamwork and Leadership • Marketing Management Required • Quality and Productivity • Health Services System • Regression Analysis for Business • Health Care Field Application Project • Microeconomics for Managers • Management Communication Electives • Comparative Health Care Systems Flexible Core: • Financial Management of Health Care Organizations Accounting • Managed Care, Market Structure, and • Financial Accounting or Health Care Delivery • Financial and Managerial Accounting or • Health Care Marketing • Accelerated Financial Accounting • Healthy Policy • Legal Aspects of Health Care Finance: Corporate Finance • Management and Economics of • Corporate Finance or Pharmaceutical and Biotechnology Industry • Accelerated Corporate Finance or • Medical Devices • Introduction to Corporate Finance • Management of Health Care for the Elderly • E-Health: Business Models and Impact Finance: Macroeconomics • Management of Health Care Services Businesses • Macroeconomics and the Global Economic • Health Care Entrepreneurship Environment or • Private Sector Role in Global Health • Introduction to Macroeconomics and the Global • Health Care Services Delivery: Economic Environment A Managerial Economic Approach • Advanced Study Project Legal Studies & Business Ethics • Responsibility in Global Management or The Health Care Summer Internship • Responsibility in Professional Services The internship is a three-month management experience which provides the health care major an opportunity Management to work with a senior executive in an organization of • Managing the Established Enterprise or particular interest to the student . • Managing the Emerging Enterprise MBA Electives Marketing Opportunities are available for the health care major to • Dynamic Marketing Strategy or pursue a second concentration in fields such as entrepre- • Strategic Marketing Simulations neurship, marketing, finance, or operations, or to pursue specialized knowledge in areas such as health care Operations financing or within specialized segments of the health care • Business Analytics or industry including managed care organizations, hospitals, • Information Technology and Business Transformation or pharmaceutical and biotechnology companies, medical • Innovation or device companies, specialty services organizations, and • Operations Strategy long term care organizations . Graduate courses are • Communications available throughout the University . • Advanced Persuasive Speaking or • Advanced Persuasion and Data Display or • Pitching Your Business

5 Andrew R. Adams Ambika K. Aggarwal John S. Barbieri [email protected] [email protected] [email protected] University of Michigan, Ann Arbor, MI Northwestern University, Evanston, IL Amherst College, Amherst, MA B .B .A ., with High Distinction, 2007 B A. ,. Economics, 2008 B .A ., Summa Cum Laude, Biology, 2009 Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA M .D . Candidate 2014

An opportunity to build successful A business development or product An opportunity to apply my clinical and health care businesses as a private management opportunity in healthcare business experiences to strategic and equity investor or manager. IT and services. operational roles focused developing innovative care models to improve the Medtronic Diabetes, Los Angeles, CA AthenaHealth, Boston, MA health of patients. Business Development Intern, Summer 2013 Product Management Intern, Summer 2013 Developed strategy for Medtronic in Developed new product plan for The Boston Consulting Group, blood glucose monitoring following recently acquired mobile health com- Philadelphia PA 70% Medicare pricing reductions . pany, Epocrates, using market research Summer Consultant, 2012 Evaluated partnership and acquisition and competitive analysis . Determined Developed analytical models and opportunities . Worked closely with beta rollout strategy including partici- conducted industry benchmarking R&D, marketing and finance teams pant recruitment, feedback surveys, analyses as part of cross-functional to ensure the recommended strategy KPIs, and product requirements and team working to develop long-term aligned with their goals . Developed identified opportunities to integrate biologics strategy plan for a major cash flow forecasts for different Epocrates into Athena’s suite of pharmaceutical company . strategies . products . The University of Pennsylvania Lake Capital, Chicago, IL Google Inc., New York, NY Health System Senior Associate, 2011-2012 Account Manager, 2010-2012 Mortality Committee Consultant, 2010 Associate, 2009-2011 Managed and optimized over $18M Redesigned mortality chart review Initiated investment opportunities, worth of annual online search and process for the Hospital of the structured acquisitions, negotiated display advertising investments for University of Pennsylvania to improve legal documentation and arranged mid and large cap pharmaceutical the number of cases reviewed and to debt financings across several manufacturers’ prescription and over- identify improvement opportunities . industries, including health care and the-counter brands . Advised clients Developed database and standardized government services, for the firm’s on new product launches and beta process for conducting and aggregat- $500M inaugural fund and $800M opportunities, increasing their ing chart reviews . second fund . Assisted with the firm’s adoption across mobile, tablet, and fundraising activities . Developed YouTube digital platforms. Measured United Community Clinics Private Placement Memorandum, and tracked campaign performance Development Director, 2010-2011 prepared dataroom, and communi- over time using Google Analytics to Responsible for operation manage- cated with investors on diligence help healthcare advertisers achieve ment of weekly, free clinic in West requests . Worked closely with man- favorable ROIs . Philadelphia . Redesigned patient flow agement teams to execute add-on to increase clinic capacity by ~10% . acquisitions, improve operations Huron Consulting, New York, NY Improved quality, efficiency, and and secure capital for growth Analyst, 2008-2010 breadth of services available through opportunities . Performed data remediation and iterative redesign of clinic processes . analysis as part of a restatement of Handled grant applications and fund- J.P. Morgan, Chicago, IL all government price points required ing for clinic, securing nearly $15,000 Investment Banking Analyst, 2007-2009 under Medicare, Medicaid, Public in funding . Advised clients in the automotive, Health Services, and Department of paper and packaging industries on Veterans Affairs laws and regulations debt and equity financings and M&A for mid-cap pharmaceutical manufac- activities . Advised Ford on its sale of turer, saving the company over $5M Volvo Car Corporation to Zhejiang in potential penalties . Geely, a Chinese automotive manufac- turer .

6 Marisa A. Bass Elissa H. Bergman Saurabh Bhansali [email protected] [email protected] [email protected] University of Pennsylvania, Philadelphia PA University of Virginia, Charlottesville, VA Northwestern University, Evanston, IL B .A ., Politics, Philosophy, and Economics, 2008 B A. ., Phi Beta Kappa, American Studies, His- B .A ., Economics, 2008 tory, 2009

An opportunity in strategy or business An opportunity to develop strategy An opportunity to discover, evaluate development for a healthcare services or improve operations for healthcare and execute on high-growth invest- or provider organization. provider organizations. ments within healthcare.

Greenway Medical Technologies, Deloitte Consulting LLP, New York, NY Ferrer Freeman & Company, San Francisco, CA and New York, NY Summer Associate, Summer 2013 Greenwich, CT Strategy Associate, Summer 2012 Assessed cost savings opportunities for Summer Investment Professional, Developed a business model and regional hospital system via non-labor, Summer 2013 implementation plan for a Population clinical and non-clinical supplies and Analyzed investments for a $900M Health Services business unit . services . Specifically, analyzed current healthcare-focused growth equity Performed competitor market state of dialysis costs and identified fund . Researched an attractive sector, research, identified internal competi- $450K in savings using industry bench- developed an investment thesis and tive advantages to determine short marks . Presented findings to stake- initiated investment opportunity and long-term development needs . holders in five different facilities and discussion . Evaluated investment Partnered internally to assess business worked to develop unified strategy platform companies and conducted unit infrastructure and funding needs; for price negotiation and savings preliminary due diligence . identified opportunities for streamlin- implementation . Collaborated with ing R&D and Marketing operations, materials management to develop Pfizer Inc., New York, NY increasing operational efficiency . streamlined purchasing strategy Senior Analyst, Business Development for various other clinical supplies . & Strategy, 2010-2012 Citi Private Bank, New York NY Assessed in-license, out-license and Head, Business Planning & Execution FTI Consulting, Washington, DC acquisition transactions across 20+ 2010-2012 Senior Consultant, 2012 therapeutics areas and stages of drug Developed and implemented new Consultant, 2009-2012 development . Managed cross-func- North America business model, infra- Coordinated and synthesized medical tional teams integrating clinical, fi- structure and sales initiatives, increas- necessity reviews performed by clini- nance, legal and marketing & sales ing investment revenue by 34% . cians from three rehabilitation facili- colleagues to frame and evaluate Managed Global Private Bank business ties that resulted in a $30M settlement commercial potential as well as invest- model implementation, sales strategy with Medicare, a total $50M below ment, technical and regulatory risks and infrastructure, increasing global original government estimate . to enable strategic decision-making . revenue 28% . Led 10-member cross- Collaborated with rehabilitation Presented recommendations to functional team to develop and imple- physicians, nurses, and case managers Executive Leadership Team that re- ment integrated business development to implement Medicare compliant sulted in company acquisitions, prod- tools, optimizing business decision- documentation and clinical processes . uct licenses or declined opportunities . making . Streamlined global invest- Managed an internal team to review a ment platform operations increasing large sample of potentially fraudulent Bank of America Merrill Lynch, operating efficiency by 23% . claims for a medical equipment New York, NY provider and created a model that Analyst, Financial Sponsors Group, Citi Private Bank, New York, NY resulted in a $65M settlement with 2008-2010 Investment Analyst, 2008-2010 Medicare . Evaluated bad-debt totals Conducted analyses and performed Instituted client segmentation strat- for 125 facilities in one of the largest due diligence for leveraged buyouts egy; performed analysis optimizing US hospital systems that resulted in and financings for financial sponsors sales force utilization, increasing 2010 $25M of tax savings for the client . that resulted in three deals completed revenue by 35% . Represented US in two-year time period . Private Bank during Morgan Stanley Smith Barney service negotiations, streamlining platform operations .

7 Alexander D. Blair Robert B. Bressler Steven D. Bressler [email protected] [email protected] [email protected] Cornell University, Ithaca, NY Duke University, Durham, NC Duke University, Durham, NC B .S ,. Magna Cum Laude, Tau Beta Pi, A .B ,. History, 2007 B .A ., French and Spanish Cultural Studies, 2007 Mechanical and Aerospace Engineering, 2007; M .Eng, Mechanical Engineering, 2008

An entrepreneurial opportunity in An opportunity to create value in An opportunity to build successful consulting or corporate development healthcare through a direct investing businesses through healthcare focused focused on healthcare strategy and or strategy role. private equity investing. innovation. Teladoc, Greenwich, CT Golub Capital, Chicago, IL Onyx Pharmaceuticals, Consultant, Corporate Finance and Summer Associate, Summer 2013 South San Francisco, CA Business Development, Summer 2013 Performed due diligence, assisted in Strategy and Innovation Intern, Reported directly to senior manage- credit agreement negotiations and Summer 2013 ment of Kleiner, Perkins backed managed junior underwriters at $8B+ Facilitated ideation of 8 transforma- healthcare IT business . Corporate AUM credit-focused alternative asset tional initiatives ($100M investment) . Finance: Point person on acquisition manager . Completed 2 debt invest- Developed case for new sourcing of competitor Consult-A-Doctor . Built ments in private equity-backed strategies ($30M investment) . Created detailed financial model, analyzed healthcare transactions . framework for innovation measure- equity awards and pro forma owner- ment and management . Led innova- ship, negotiated legal documents and Frazier Healthcare, Seattle, WA tion think tank topics creation . ran due diligence process . Business Associate, 2010-2012 Development: Managed 12 person Performed financial and operational Deloitte Consulting, Boston, MA team to implement new offering in due diligence, evaluated markets and Consultant, 2008-2012 dermatology . Crafted business case management teams and constructed Developed integration strategy for 250 and bottom-up model to asses market bottom-up forecast and returns clinical trials representing $14B in R&D opportunity . models for a $1 .8B AUM healthcare- investment . Led integration of 50 focused private equity firm investing a clinical trials . Integrated clinical trial Ares Management, New York, NY $620M fund . Closed 3 platform invest- support and oversight model for over Associate, 2009-2012 ments (pharmaceutical packaging, 30 countries . Managed clinical trial Executed a range of investments dialysis and distribution) and 2 follow- quality standards development across with a focus on healthcare . Directly on acquisitions (behavioral health and 200 stakeholders; Improved trial invested ~$1B in debt and equity dialysis) . quality 10% (est .) . Facilitated design capital . Sourced new opportunities, sessions with C-level stakeholders . executed due diligence to evaluate Shattuck Hammond Partners, Created dynamic, adaptable organiza- target company business models, Atlanta, GA tional model . Managed 50 person formulated investment theses and Senior Analyst, 2010 project team . Coordinated distribution robust forecast models, negotiated Analyst, 2008-2010 of $1 .2B of health services . legal documents, worked closely with Provided origination, execution and portfolio company management teams analytics on $1 .3B of closed M&A, Clinton Health Access Initiative, and evaluated add-on acquisitions . debt and derivative transactions at the Mbabane, Swaziland Sole junior investment professional boutique healthcare investment bank- Program Analyst, Summer 2012 involved in acquisition and sale of ing division of Morgan Keegan & Co . Analyzed expenditures and negotiated healthcare IT / services business . Served clients including hospitals, new unit rates with vendors, reducing healthcare services companies and costs by 76% and expanding program Citigroup Healthcare Investment private equity firms . coverage . Forecasted 4 year program Banking, New York, NY budget for 7 functional areas . Unified Analyst, 2007-2009 Katzenbach Partners, Houston, TX strategic planning process across Executed advisory and capital raising Associate, 2007-2008 program . transactions . Notable buy-side assign- Management consultant tasked with ments: Kimberly-Clark’s acquisition analyzing and advising clients on of I-Flow; Attempted acquisition of corporate strategy and new business TriZetto by large MCO initiatives . Completed board presenta- tions, customer segmentation analyses and new product launch studies .

8 Frank L. Brodie Qian Cai, Ph.D. Elena C. Castañeda [email protected] [email protected] [email protected] Carleton College, Northfield, MN Fudan University, Shanghai, China Harvard College, Cambridge, MA B .A ., Cum Laude, Political Science, 2005 B S. ., Chemistry, 1998 A .B ., Engineering Sciences, Perelman School of Medicine at the University Heriot-Watt University, Edinburgh, U .K . Biomaterials, 2008 of Pennsylvania, Philadelphia, PA M Phil. ., Mechanical Engineering, 2003 M .D . Candidate, 2014 University of Cambridge, Cambridge, U .K . Ph .D ., Biomaterials, 2007

An opportunity to develop and An opportunity to combine my industry An opportunity to invest in healthcare commercialize new medical technology and business expertise with finance services, IT or biopharmaceuticals that directly impacts patient care. knowledge for healthcare investment through venture capital or corporate or business development. development. Maculens Vision Technology, Philadelphia PA Citigroup, London, England Johnson & Johnson, New Brunswick, NJ Co-Founder, 2012 - Present Intern Associate, Summer 2013 Summer Associate, Mergers & Acquisitions, Based on technology developed by Prepared valuation for a biotech Summer 2013 ophthalmologists at the University of company using DCF, precedents and Managed clinical, financial and legal California, Maculens provides a novel comparables to form the basis of price due diligence work streams for multi- optical coating that dramatically negotiation . Conducted extensive ple potential oncology acquisitions . decreases the glare and discomfort industry/market research to help Conducted interviews with internal drivers experience from oncoming prospective clients identify business clinical experts, synthesized research headlights at night . Winner of the opportunities . Responsible for moni- data and presented findings to senior People’s Choice Award and 2nd Place toring market movements and broker leadership . overall in the 2013 Wharton Business consensus and communicating key Plan Competition, Maculens has information to the client . Kapor Capital, San Francisco, CA developed a strong advisory board of Summer Associate, Summer 2012 industry leaders and expects revenue Baxter Healthcare, London, England Conducted thorough review of five in Q1 2014. Research Scientist/Project Manager/ healthcare portfolio companies to ed- Researcher, 2006-2012 ucate venture partners in advance of General Mills, Golden Valley, MN Led new technology development several follow-on portfolio company Marketing Associate, 2005-2007 project on stem cell-based bone graft funding discussions . Review informed In the Food Service division I was substitutes with 3 external institutions . decisions on whether to reinvest in responsible for growing the business Assessed and recommended new tech- portfolio companies . Led due diligence with large restaurant chains by provid- nologies and companies to Baxter’s exercises on five potential health tech ing marketing support to the restau- acquisition team . Conducted R&D investments . Generated and confirmed rants as well as developing new Benchmarking research for the ortho- hypotheses of market value . products to sell in . Additionally biologic field . Drafted and published 2 coordinated with logistics, finance patents on new polymer formulae for Insight Strategy Advisors, New York, NY and supply teams to reduce costs and medical device applications . Designed Senior Analyst, 2011-2012 rationalize our supply chain . The and analyzed VOC Programs to under- Analyst, 2009-2011 following year in the Snacks division stand customer expectations and Led research programs for and later I was responsible for leading a requirements . managed consulting engagements in- cross-functional team in developing, cluding pricing/contracting, marketing branding and positioning a new Shanghai NetZeal Co. (Entrepreneurial strategy, payer segmentation, line of healthy snacks for children . Experience), Shanghai, China and emerging market drug value Business Development Manager, propositions for pharmaceutical, 1998-2001 medical device and biotech clients . Delivered business planning and Recommended acquisition of oncology oversaw accounting and administra- startup to a client after thorough tive activities . Established and market assessment examining market maintained relationships with key growth, competitive analysis, and business partners . Worked with forecast financials of lead compound . software developers to deliver Client completed recommended $1B solution-based-selling . acquisition 2011 .

9 Pablo Cervera Alexander L. Chin Yuming A. Chiu [email protected] [email protected] [email protected] Instituto Tecnologico Autonomo de Mexico, Yale University, New Haven, CT University of California, Los Angeles, CA Mexico City, Mexico B S. ., Summa Cum Laude, B .A ., Economics, B .A ., Music Performance, 2007 B .A ., Economics, Honorable Mention, 2008 Molecular Biophysics & Biochemistry, 2009 Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA M D. . Candidate, Alpha Omega Alpha, 2014

An opportunity in strategy or policy An opportunity to integrate my medical An opportunity to market consumer definition within the health care space, and business expertise to improve health products in emerging economies with special focus on developing design of health care delivery systems. to improve basic health and nutrition. countries. McKinsey & Company, Summit, NJ General Mills, Inc., Minneapolis, MN Clinton Health Access Initiative, Summer Associate, Summer 2013 Associate Marketing Manager Summer Pretoria, South Africa Developed long-term strategic initia- Intern, Summer 2013 Volunteer Analyst, Summer 2013 tives for large national hospital system Repositioned national marketing Optimized antiretroviral needs projec- to prepare for and adapt to challenges strategy for dry packaged potatoes tion for the South African Department of health reform . Responsible for portfolio to capture regional consumer of Health, generating a more robust understanding the changing role of insights and developed retail sales tool for planning medicine procure- physicians in the health care system material to capitalize on price elastic- ment on a 3 year horizon . and how physicians, hospitals, and ity in $488M category . Led creation of payors can collaborate to enhance $100,000 national and regional digital McKinsey and Company, quality and improve delivery of campaign for dry packaged potatoes Florham Park, NJ medical care . for key purchasing season . Senior Analyst, 2011-2012 Completed projects in mid to large size Hospital of the University of International Justice Mission, pharmaceutical companies, including Pennsylvania, Department of Mumbai, India regional strategy definition and priori- Radiation Oncology, Philadelphia, PA Business Operations and tization, business development and Research Associate, 2012-Present Relations Fellow, 2010-2012 evaluation of in-licensing opportuni- Studied feasibility of using magnetic Developed strategy for anti-trafficking ties, organizational optimization of resonance imaging alone for radiation casework proposal which outlined R&D function, global launch strategy treatment planning for head and neck 3-year ground-level strategies, deliver- of oncological drug and positioning cancers . Awarded oral presentation at ables and required resources budgeted within the company’s expanded annual American Society for Radiation at $3 .1M; led successful implementa- portfolio . Oncology conference . tion to meet operational targets in first year . McKinsey and Company, Johnson & Johnson Pharmaceutical Mexico City, Mexico Research and Development, PricewaterhouseCoopers LLP, Analyst, 2009-2011 Titusville, NJ Los Angeles, CA Worked across industries in over 10 Summer Intern, Summers 2006-2008 Senior Associate – Consulting, 2009-2010 projects, focused on strategy defini- Designed protocol elements for Phase Associate – Consulting, 2007-2009 tion . Worked closely with senior clients III study of novel antipsychotic that Created monitoring tools and pro- and internal experts to develop solu- contributed to FDA approval . cesses to evaluate $150M sales and tions to client specific strategic issues, Collaborated with cross-functional marketing spend in gifts, meals, enter- using management tools and best team of academic and National tainment, and speaker fees on HCPs practices to propose strategic alterna- Institutes of Health physicians that for large biotechnology company, tives . Examples of projects include net- established new targets for drug which provided insight into commer- work design in telecommunications, development . cial operations spend . Developed pro- development of 5 year strategic ductivity benchmark and analysis tool plan for and upstream oil company, to measure 9-member hospital system, revenue projection for specific and identified and corrected process medicines in a due diligence . inefficiencies, which led to reduction of over $10M in costs .

10 Brett L. Chung Edward S. Chung Anne DeCourcy [email protected] [email protected] Conlin Columbia University, New York, NY University of Virginia, Charlottesville, VA B .S ,. Biomedical Engineering, 2007 B S. ., Finance and Accounting, 2007 [email protected] Harvard College, Cambridge, MA A .B ., Cum Laude, Social Studies, 2007 Certificate in Health Policy, 2007

An opportunity to develop products in An opportunity to build successful An opportunity to work with a payor healthcare services and technology. healthcare service companies through or provider organization to develop private equity investing. strategies that respond to changing TangramCare Corporation, Irvine, CA policies and improve efficiency. MBA Intern, Product Management, The Beekman Group LLC, New York, NY Summer 2013 Summer Associate, Summer 2013-Present McKinsey & Company, Summit, NJ Managed product development for 2 Evaluated investment opportunities Summer Associate, Summer 2013 digital health screening technologies in service-based companies on behalf Supported a leading national payor in for bipolar disorder and intimate of the $200M private equity fund . preparation for insurance distribution partner violence . Led research efforts, Created investment thesis for outpa- through Health Insurance Exchanges competitive analysis, and product tient physical therapy, conducting under healthcare reform . Developed design for TangramCare’s telehealth industry interviews and identifying a policy-sensitive model to quantify technology for elderly patients . key investment risks and due diligence Individual coverage uptake in low benchmarks . Prepared long-term income populations in 25 states . Spinal Muscular Atrophy (SMA) strategic plan and assessed market Foundation, New York, NY expansion opportunities of an interna- IMS Health Management Consulting Project Manager, Operations & tional air ambulance business leading Group, Singapore Clinical Development, 2010-2012 company to pursue a new domestic Senior Consultant, 2010-2012 Research Associate, service line . Led consulting teams in developing Translational Research, 2008-2009 growth strategies for pharmaceutical Developed and commercialized SMA The Providence Service Corporation, multinationals operating in Asian Enzyme-Linked Immunosorbent Assay Tucson, AZ emerging markets . Built expertise in in conjunction with Enzo Life Sciences . Strategy Analyst, 2010-2012 innovative pricing strategies for base Led development of bioinformatics Led review of >40 mental/behavioral of the pyramid consumers . Developed tool for genomics analysis in SMA pa- health and medical transportation a public/private sector strategy for a tients . Served as clinical development acquisition targets with values ranging global vaccines company’s Indonesian consultant to Isis Pharmaceuticals and from $1M to $100M . Managed due market entry . provided technical expertise on central diligence and legal documentation nervous system drug delivery for suc- of a behavioral health add-on acquisi- Clarion Healthcare Consulting LLC, cessful filing of FDA IND application tion . Created coverage effort around Boston, MA for lead SMA compound . $300M workers compensation trans- Associate, 2007-2010 portation market, $30B home health Designed process for prescription ful- Accenture, New York, NY market and growing dual eligible fillment and administration support Analyst, 2007-2008 population . Evaluated marketing and for a specialty pharmaceutical product Analyzed performance metrics and referral process of subsidiary foster and developed patient support pro- resource allocation for technology care business to discover $5M of gram to reduce leakage across treat- implementation project (global insur- missed revenue opportunity . ment settings . Assessed opportunities ance client) . Trained and coordinated for creation of a patient registry and global design teams to develop Signal Hill, Baltimore, MD disease management system for a baseline requirements for technology Investment Banking Analyst, 2007-2010 biotechnology company . solution . Assisted senior executive Focused on sell-side M&A engage- with a pro-bono consulting project to ments for high-growth technology, increase online donations for Komen media, and government sponsored for the Cure New York. healthcare companies completing 7 investment banking transactions, totaling $500M of value .

11 Jennifer A. D’Ascoli Nikhil Devulapalli Divya Dhar, M.D. [email protected] [email protected] [email protected] Massachusetts Institute of Technology, Cornell University, Ithaca, NY University of Auckland, School of Medicine, Cambridge, MA B S. ., Summa Cum Laude, Applied Economics Auckland, New Zealand S .B ,. Chemistry, S .B ., Biology, 2008 and Management, 2007 MBChB, 2009 Harvard Kennedy School of Government, Cambridge, MA M .P .A . Candidate, 2014

A patient-centric commercial marketing An opportunity to build leading An opportunity to identify, lead and opportunity, focused on chronic or rare healthcare companies through execute on innovative healthcare diseases, within the biopharmaceutical effective investment and management. information technology or service industry. businesses from idea generation to Carlson Capital, New York, NY full-fledged business. Genentech, South San Francisco, CA Summer Analyst, Equity Special Situations Market Planning Intern, Summer 2013 Group, Summer 2013 Seratis, Philadelphia, PA Led a project investigating the drivers Sourced and evaluated public equity Co-founder and CEO, Summer 2013-present and barriers to the use of Perjeta® opportunities with hard catalysts Formulated vision, raised seed capital in HER2+ metastatic breast cancer, (spin-off, split-off, merger), with a of $42000 and executed usability test- to inform tactics to drive Perjeta focus on analyzing industry structure ing for beta product at Penn Medicine . adoption in the first line setting . and competitive dynamics and build- Selected to participate in DreamIT Synthesized insights across primary ing detailed bull/bear case operating Health Accelerator Program . market research, internal experiences and financial models . and strategies, as well as secondary Global Innovation for Translation (GIFT), data, and collaborated with brand H.I.G. Capital, New York, NY Bangalore, India team to plan implementation of Private Equity Associate, 2010-2012 Co-founder and Team lead, Summer 2012 recommendations proposed by Engaged in all aspects of investment Formulated vision, wrote business plan research . processes including due diligence, and raised seed capital of $20000 . modeling, financing, deal negotiation, Launched incubator to bring together Health Advances, Weston, MA and post-acquisition support for global multi-disciplinary team of Harvard Consultant, 2011-2012 private equity firm with $13B under students for global health summer Senior Analyst, 2009-2011 management . Closed 3 transactions immersion program . Led team of Analyst, 2008-2009 in the surgery center, dental practice four students to identify needs in Strategy consultant for clients in management, and managed care Cardiothoracic Surgery, Cath Lab pharmaceutical, biotechnology, industries, and served as a board and Ophthalmology in Narayana diagnostic, and medical device observer for 2 companies . Hrudayalaya and Aravind Eye industries . Led project teams of Hospitals . Idea generated that is 2-4 consultants, coordinating team Thomas H. Lee Partners, Boston, MA being developed into medical device activities and synthesizing quantitative Private Equity Associate, 2009-2010 at Harvard Labs . and qualitative primary research and Conducted extensive industry and secondary market data into key client company-level due diligence to ana- Auckland and Counties Manukau District deliverables . Designed qualitative and lyze investment opportunities within Health Board, Auckland, New Zealand quantitative research tools (interview the consumer and retail sectors for House Officer (Resident), 2009-2011 guides, surveys, conjoint) and devel- private equity firm with $10B under Diagnosed, treated and formulated oped market forecasts, valuation management . Oversaw 2 portfolio management plan with follow up for models, and screening databases companies, monitoring performance patients in a range of specializations . to aid clients in investment decisions . and evaluating strategic initiatives Communicated diagnosis and plan alongside management . effectively with staff, patients and their families to coordinate care . Goldman Sachs & Co., New York, NY Investment Banking Analyst, Consumer / Retail Group, 2007-2009 Analyzed financial implications of M&A, divestiture and leveraged buy- outs transactions and coordinated with management on key aspects of the sell-side process .

12 Corbin R. Director Manuel L. Donnay Penny Q. Fang [email protected] [email protected] [email protected] Colgate University, Hamilton, NY Columbia University, New York, NY Harvard College, Cambridge, MA B .A ., Physical Science, 2007 B S. ., Magna Cum Laude, A .B ., Summa Cum Laude, Phi Beta Kappa, Mechanical Engineering, 2006 Neurobiology, 2009 Stanford University, Stanford, CA Perelman School of Medicine at the University M S. ., Mechanical Engineering Design, 2008 of Pennsylvania School of Medicine, Philadelphia, PA M .D . Candidate, 2014

An opportunity to use my healthcare An opportunity to solve challenging An opportunity to thoughtfully improve services and IT background to build strategy and marketing problems within health care delivery and patient out- earlier-stage healthcare businesses. health care. comes using my expertise in medicine and business. RxAnte, McLean, VA The Boston Consulting Group, Summer Strategy Associate, Summer 2013 San Francisco, CA Hospital of the University of Led the creation of initial ROI and Summer Consultant, Summer 2013 Pennsylvania, Department of Radiation competitive landscape analyses, built Developed model to analyze aftermar- Oncology, Philadelphia, PA financial projection model, and pro- ket revenue growth opportunity for Clinical Research Intern, vided strategic guidance and analysis client in the aerospace industry and Summer 2012-Present on product positioning and pricing helped develop subsequent implemen- Determine differences in clinical toxic- for RxAnte, a predictive analytics and tation plan . Planned and directed ity between patients treated with decision support technology platform weekly client meetings to ensure this proton beam and intensity-modulated that forecasts medication behaviors to initiative moved forward according radiation therapy for prostate cancer . help healthcare organizations improve to plan . Conduct Phase I study using a novel outcomes and reduce costs . radiosensitizer in glioblastoma Abbott Diabetes Care, Alameda, CA patients undergoing radiotherapy . Radius Ventures, New York, NY Mechanical Engineer II, III, IV, 2008-2012 Perform analyses of drivers of differ- Associate, 2011-2012 Led design of device from conceptual- ences in patient quality of life after Sourced and evaluated new invest- ization to final build for two medical undergoing radiation therapy for ments in medical technology, device product lines . Produced innova- breast cancer . healthcare services and healthcare IT tive customer-focused design solutions companies . Led scientific, regulatory, that successfully integrated human Massachusetts General Hospital, reimbursement, market, financial and factors considerations . These designs Department of Radiation Oncology, legal due diligence efforts . Conducted increased first time user success rates Boston, MA primary interviews, wrote investment by 34% and reduced average patient Advanced Sub-Intern, Summer 2013 memorandums, negotiated term perceived pain scores by 48% . Engage in patient care, present sheets and modeled deal return sce- Synthesized input from Global detailed medical information to narios . Supported portfolio companies Strategic Marketing team and physician-led team and formulate on a variety of initiatives including designed products that simplified the treatment solutions . Assist with tech- cash and financial forecasting, sales user experience by reducing the num- nical aspects of treatment planning strategy, M&A, fund raising, recruiting ber of user assembly steps from 13 to and delivery of radiation therapy . and compensation planning . 6 . Managed external development teams that successfully integrated Penn Language Link, Philadelphia, PA Ziegler, New York, NY design components on budget and Medical Student Coordinator, 2009-2013 Associate, 2010-2011 ahead of schedule . Collaborated with Coordinate training of and manage Analyst, 2007-2010 suppliers and third party manufactur- medical student interpreters Provided financial and strategic ers in Europe and Asia to ensure volunteering in the University of corporate advice to founder-focused successful knowledge transfer . Pennsylvania Hospital System and healthcare information technology affiliated free clinics . Secure funding and healthcare services companies for professional training services for on M&A, capital raising, and strategic student interpreters and coordinate advisory assignments . multi-session programs . Match patient demand for language assistance with qualified interpreters .

13 Andrew N. Franklin Andrew A. Glowalla Alan J. Han [email protected] [email protected] alan.han@[email protected] University of Pennsylvania, Philadelphia, PA Pomona College, Claremont, CA Dartmouth College, NH B .S E. ., Summa Cum Laude, B A. ,. Mathematical Economics and Russian, A .B ., Cum Laude, Economics, 2008 Bioengineering, 2006 2004 University of Pennsylvania School of University College London, London, England Applied Sciences, Philadelphia, PA M .Sc ., Distinction, Biochemical Engineering, M .B . (Biotech) Candidate, 2014 2007

An opportunity in strategy or A strategic or operational role to An opportunity to build and develop operations for a biopharmaceutical improve health care delivery in the U.S. biopharmaceuticals companies. or health technology company. Kaiser Permanente, Oakland, CA Genentech, Inc. San Francisco, CA Genentech, South San Francisco, CA Quality and Operations Support Consultant, Summer Intern, MBA Intern, RITUXAN Market Planning, Summer 2013 Pulmozyme Brand Team – Strategy Summer 2013 Developed protocols to optimize Summer 2013 Led a project to revitalize promotional patient scheduling for mammography Developed the access and reimburse- messaging for the Hematology that are currently being tested in 3-site ment recommendations for the launch Franchise to drive Rituxan mainte- pilot . Created framework for develop- of a novel method of delivery for a nance adoption . Managed primary re- ment of clinical decision-making path- biologic for cystic fibrosis . Led a cross- search with healthcare practitioners to ways used in emergency department functional team within Genentech to identify the most compelling messages observation area . Devised perfor- develop both quantitative NPV analy- by customer segment . Collaborated mance improvement plan for pharma- ses and qualitative considerations . Also with a cross-functional team to con- cotherapy management of COPD worked on the promotional side, struct new promotional material and exacerbation, including potential developing recommendations for a provide field direction based on solutions related to billing, EMR, new class of virtual speaker program . market insights . data capture and physician education . Trinity Partners, New York, NY Merck & Co., West Point, PA DaVita, El Segundo, CA Consultant, 2011-2012 Biochemical Engineer, 2008-2012 Manager, Process Improvement, 2012 Associate, 2009-2011 Conducted hypothesis-driven experi- Senior Business Analyst, 2010-2012 Conducted strategic analysis for life ments to improve product quality and Crafted vision for new quality assess- sciences companies, working on over ensure robustness as processes were ment program and led cross-functional 25 engagements for clients ranging scaled-up for manufacturing . Directed 20-person team to execute plan . from top 10 pharmaceutical companies manufacturing process development Designed financial model to ascertain to biotechs . Advised on launch plan- for two early stage vaccine candidates effects of new Medicare bundled pay- ning, licensing and acquisitions, corpo- as part of a shared leadership team . ment system . Managed team to create rate strategy, pipeline prioritization, Managed a staff of six to design, plan, clinical acquisition review program . and pricing/reimbursement with a and execute bioreactor experiments Directed analytics and project manage- focus on oncology, women’s health, and generate research cell banks . ment for regulatory effort . and inflammatory diseases . Staffed Championed an initiative to improve as a project manager . the quality of data collected during GGL Global Gaming, Los Angeles, CA bioprocess manufacturing . Secured Senior Associate, Corporate Development, Bank of America Merrill Lynch, $500,000 in funding to install superior 2006-2010 New York, NY production monitoring equipment . Built and maintained company’s Investment Banking Analyst, Designed data analysis tools to five-year integrated financial model . Healthcare Group, 2008-2009 efficiently characterize production Managed email marketing depart- Conducted qualitative and quantita- performance . ment . Directed web analytics tive financial analyses for the health- program, improving user conversion care services, medical technologies, by 40% . and life sciences sectors for M&A, IPO, and capital raisings . Developed in- Lazard, San Francisco, CA depth quantitative modeling and Investment Banking Analyst, 2004-2006 transaction experience . Advised public corporations, private companies and financial sponsors on strategic issues including M&A and divestitures .

14 John A. Harroff Daniel K. Harvey S. Jawad Hasan [email protected] [email protected] [email protected] Brown University, Providence, RI Duke University, Durham, NC University of Michigan, Ross School of Business, B .A ., Economics / International Relations, 2007 B S. ., Magna Cum Laude, Economics, 2009 Ann Arbor, MI Bachelor of Business Administration, 2008

An opportunity in private equity with An opportunity to impact the strategy A direct investing opportunity with ex- exposure to the healthcare sector. and operations of businesses in the posure to the healthcare sector. healthcare sector. Essex Woodlands, Palo Alto, CA / Viking Global, New York, NY New York, NY Gay & Lesbian Latino AIDS Education Summer Analyst, Summer 2013 MBA Associate, Summer 2013 Initiative, Philadelphia, PA Identified and analyzed long/short Evaluated 20+ healthcare growth eq- MBA Volunteer, Summer 2013 equity investments in the financial uity investment opportunities for the Engaged with organization leadership and technology sectors for $22B firm’s $900M eighth fund, including to create business plan for launch of hedge fund . a healthcare IT provider, a specialty a revenue-generating opportunity to pharmacy, a medical device contract support the non-profit’s ongoing Great Hill Partners, Boston, MA manufacturer, and a hospice company . operations . Associate, 2010-2012 Analyzed, structured, and closed on a Contributed to all aspects of invest- $30M convertible note financing for United Nations Global Compact, ment process, including transaction an existing portfolio company . New York, NY sourcing, screening, company and in- LEAD Special Advisor, 2011-2012 dustry research, business and financial Riverside Partners, Boston, MA Seconded from The Boston Consulting analysis, modeling, valuation, structur- Associate, 2010-2012 Group . Influenced UNGC LEAD compa- ing, negotiation, documentation, and Evaluated and executed potential nies through development, implemen- post-close value creation . Transaction investment opportunities across the tation, and support of task forces on experience includes $70M majority eq- healthcare and technology sectors relevant sustainability topics . Advised uity investment in Ascenty, a provider for the firm’s $406M fourth fund . UNGC office on design and implemen- of high bandwidth connectivity and Performed strategic, financial, and tation of commitment framework and data center solutions in Brazil . operational due diligence on 50+ in- associated accountability metrics . vestment opportunities . Built financial UBS Investment Bank, New York, NY models for investment evaluation The Boston Consulting Group, Analyst, 2008-2010 process, including LBOs and merger New York, NY Transaction experience includes $1 3B. models for add-on M&A . Board Consultant, 2011-2012 buy-side M&A advisory, $200M sell- observer at six different portfolio Associate, 2009-2011 side M&A advisory, $305M stock companies, collaborating with Developed project management office offering, $200M bond placement, management on issues related to as part of post-merger integration for and $590M credit facility refinancing . corporate strategy, financial markets beverage manufacturer, resulting in and acquisition/de-novo/line extension $300M in synergies . Performed growth opportunities . Closed six deals includ- analysis and opportunity assessment ing two LBOs, two add-on acquisitions, for global biopharmaceutical and two portfolio company exits . company, resulting in large-scale organizational redesign . Implemented BMO Capital Markets, New York, NY country integration for company’s Analyst, 2007-2009 chemical division, including project Active participant on deal teams origi- management and implementation of nating and executing M&A, public and new business unit . Assessed biologics private equity offerings, and debt and formulation and delivery technology refinancing transactions . Advised through top-down and bottom-up clients across the medical technology, opportunity identification . Globalized healthcare services, pharmaceutical, supply networks to reduce expenses and biotechnology sectors . Closed for major biopharma by implementing three deals during recessionary a new operating model with environment . multi-stakeholder engagement .

15 Jane L. Herzeca Breanna M. Bob Huang, M.D. [email protected] [email protected] Duke University, Durham, NC Hockenbury University of New South Wales, A .B ., Cum Laude, Public Policy Studies breanna.hockenbury.wg14@ Sydney, Australia and Economics, 2009 wharton.upenn.edu M .B .B .S ., Honors, 2009 University of Virginia, Charlottesville, VA B .Sc ., (Med) Honors, 2008 B A. ,. Economics, B .A ., English, 2008

A strategic or entrepreneurial An opportunity to help businesses best To entrepreneurially develop or join opportunity in health care services position themselves for changes in the teams in creating technology-enabled and technology. healthcare industry. solutions to healthcare problems.

Aidin, New York, NY (Health IT Startup) Benefitter, San Francisco, CA 1DocWay, New York, NY VP of Implementation Services, Business Development Intern, Summer 2013 Business Development, Summer 2013 Summer 2013 Secured mission-critical, nationwide Created and deployed new marketing Guided implementation of Aidin partnerships with health insurance and sales strategy for telepsychiatry software suite with a major hospital web brokers for a VC-backed startup services, refocused company on 500+ system, including registering 500+ that is developing employee benefits high potential leads and doubled post-acute care providers and provid- SAS solutions for businesses . conversion rates . Devised innovative ing ongoing user support and product Researched potential partners, pricing model that captured additional management . Worked with CEO and developed and managed RFP process, revenue streams from state govern- COO to develop marketing strategy selected partner and negotiated final ments . and materials to drive higher sales contract agreements . Managed 51 conversion rate . state-level insurance licensing Bain & Company, Sydney/Shanghai processes to ensure firm could bill Senior Associate Consultant 2011-2012 The Advisory Board Company, revenue in every U .S . state and DC . Associate Consultant 2010-2011 Washington, DC Key projects: Assessed pharma, con- Senior Analyst, 2011-2012 Booz Allen Hamilton, Washington, DC sumer health care and point-of-care Analyst, 2010-2011 Associate, 2011-2012 diagnostics markets and recommended Research Associate, 2009-2010 Senior Consultant, 2009-2011 new product launches as a part of Completed 4 best-practice research Consultant, 2008-2009 China strategy revamp for top phar- studies for a client base of 450+ hospi- Developed a seven-year, $829M strate- maceutical company . Built business tal CEOs, CMOs, COOs and CNOs . For gic plan to close Walter Reed hospital case for cloud computing IaaS business each project, interviewed 80+ execu- and merge four hospitals and thirty- for large Chinese network equipment tives at major health systems, analyzed two clinics into one integrated delivery manufacturer . Advised large findings and developed final presenta- system . Included a 500,000 patient Australian health insurer on adjacency tion deliverables . Served as in-house population analysis and multi-Service moves by analyzing local health indus- expert by answering client questions business plan to optimize health care try trends and innovative solutions and providing research framing for delivery . Managed a $200,000 contract overseas . presentations on hospital case and four consultants conducting mar- management, emergency depart- ket research of over 500,000 military Face 2 Face UMAT Preparation Center ments, interdisciplinary care planning, patients . Managed the collection, Founder and CEO, 2004-Present inpatient/outpatient care coordina- analysis and integration of data to Founded coaching college that pro- tion, as well as cancer center opera- develop a new health and wellness vided in-class teaching and online tions, referral patterns, and staffing strategy . Developed and managed a materials to help thousands of models; results would lead to more national launch strategy for a new students prepare for medical school efficient, lower cost, and higher mobile health management program entrance exams in Australia, grew quality care delivery . targeted at over 6M people . company revenues from $15,000 to over $300,000 in less than 5 years, propelling company to become second largest player in market .

16 Vivek Jain Niti Kadakia Hee-Won Kang [email protected] [email protected] [email protected] Cornell University, Ithaca, NY The Wharton School, University of Barnard College, Columbia University, B .S ,. Cum Laude, Electrical and Computer Pennsylvania, Philadelphia, PA New York, New York Engineering, 2006 B S. ., Cum Laude, Economics, B .A ., Magna Cum Laude, Economics, Major in Finance and Accounting, 2007 Psychology, 2005

An opportunity to build successful An opportunity to improve the health A dynamic marketing role where I can businesses through effective investment of populations through system-wide use innovative strategies to improve and management. innovation around efficiency and access. health outcomes.

Novartis AG, Basel, Switzerland MissionPoint Health Partners, Pfizer, New York, NY Summer Associate, Mergers & Acquisitions, Nashville, TN Marketing Summer Associate, Summer 2013 Summer 2012 Strategy and Business Development Intern, Formulated new segmentation and Evaluated acquisition of early stage Summer 2013 targeting strategies for Pfizer’s #1 ophthalmology focused company . Developed concept, business case, brand to harness untapped opportuni- Collaborated with commercial and de- financial analysis and prototype design ties in the trade channel . Identified velopment teams to create probability plans for an ACO retail presence to and evaluated innovative acquisition adjusted valuation . further the organization’s ability to and adherence tactics to maximize bridge gaps in health care delivery and ROI . Collaborated cross-functionally H.I.G. Capital, New York, NY education . Also created cost projection and directed agencies to design 2013 Private Equity Associate, 2009-2012 models for on-site clinic services and pilot programs . Presented actionable Engaged in all aspects of private built physician payment analyses to recommendations to senior leadership equity investing process including improve clinical partner relationships . resulting in an additional $3M in business diligence, financial modeling, MissionPoint is a subsidiary of budget approvals . financing, investment committee Ascension Health . presentations, deal negotiation, post- Children’s Hospital of Philadelphia, acquisition support and portfolio mon- PricewaterhouseCoopers LLC, Philadelphia, PA itoring for $1 .5B Middle Market Fund . Philadelphia, PA Clinical Research Assistant, 2010-2012 Transaction Services Senior Associate, Launched first-of-its-kind study part- Citigroup, New York, NY 2010-2012 nering with Pfizer to identify autism Investment Banking Analyst, 2006-2009 Managed teams to determine health biomarkers for commercial develop- Provided financial and strategic advi- industry client business enterprise and ment . Leveraged cutting-edge technol- sory services within the healthcare asset valuations for various purposes ogy to measure new types of data . Led investment banking group . Advised including mergers, acquisitions, dives- project operations and trained 7 staff, clients across the pharmaceutical, titures, tax planning and financial completing milestones within budget medical device and healthcare services reporting . Also conducted pre-deal and aggressive 2-year timeline . sectors . due diligence and benchmarking studies . Contributed to the develop- Accenture, Cleveland, OH ment of the valuation health industry Consultant, 2005-2010 practice . Led cross-functional teams ranging 10-30 people, consisting of clients, PricewaterhouseCoopers LLC, consultants and offshore programmers New York, NY over 6 project lifecycles . Transformed Financial Instruments and supply chain management strategy Credit Senior Associate, 2007-2010 across manufacturing and government Consulted with financial services clients . Leveraged big data and inte- industry clients around valuation, grated IT solutions to enable real-time operational and risk management reporting and data-driven decision- considerations of complex financial making . Achieved operational instruments and structured products . efficiencies and savings (up to ~$75M) .

17 Eric W. Klein Sri Kotte Brian A. [email protected] [email protected] Lewandowski University of Pennsylvania, Philadelphia, PA University of California, San Diego, B .S ,. Economics, B .A ., Political Science, La Jolla, CA [email protected] Summa Cum Laude, 2007 B S. ., Cum Laude, Bioengineering, 2008 Princeton University, NJ A .B ., Honors, Phi Beta Kappa, Politics, 2005

An opportunity to build successful An opportunity to use my technical An opportunity to make intelligent businesses through healthcare focused and business expertise to innovate investments in the healthcare sector. private equity investing. new solutions to improve health care and grow a business. RA Capital, Boston, MA American Securities, New York, NY Research Analyst Summer Associate, Summer 2013 Allazo Health, New York, NY Summer 2013 Identified attractive healthcare Marketing & Business Development Lead, Conducted fundamental long/short services opportunities for private Summer 2013 equity due diligence on small/mid-cap equity firm with $3 .6B in latest fund . Developed commercialization plan and biotech companies . Key projects branding strategy for healthcare data included analyzing unique competitive Vestar Capital Partners, New York, NY analytics startup . Assisted CEO in the dynamics for an array of U .S . clinical- Associate, 2010-2012 negotiations with specialty pharmacy stage compounds, and constructing Conducted extensive industry and client on a multi year sales agreement . a market model for multiple liver company-level due diligence to Helped establish pricing strategy for disease indications . analyze investment opportunities core product offering . Oversaw devel- within the healthcare services sectors opment of new website, which helped Sonar Capital, Boston, MA for private equity firm with $3 5B. in increase inward sales leads . Associate Portfolio Manager, 2009-2012 latest fund . Oversaw 3 portfolio Research Analyst – Healthcare, 2007-2009 companies, monitoring performance CareFusion, San Diego, CA Managed independent long/short and evaluating strategic initiatives R&D Engineer, 2009-2012 equity portfolio focused on fundamen- alongside management . Select transac- Led the design and development of tally-driven strategies in the healthcare tion: $500M acquisition of World a variety of medical devices ranging sector, outperforming the S&P500 Courier, a specialty logistics provider from robotic surgical instruments, each year from 2009 to 2012 . Directed (outbid by strategic) . next generation breathing circuits for profitable expansion of primary long/ ventilators to drug-eluting catheters . short healthcare portfolio into the Eos Partners, New York, NY Invented a patent pending mounting medical device sector . Associate, 2009-2010 arm subsystem for laparoscopic Only Associate working with 10 person surgery, which reduced set-up time by Putnam Associates, Burlington, MA investment team to evaluate PE and 50% . Managed multi-disciplinary team Associate Consultant, 2006-2007 distressed debt investment opportuni- comprised of marketing, quality, man- Analyst, 2005-2006 ties for private equity firm with $700M ufacturing and regulatory through the Provided strategic consulting services in latest fund . Select transaction: $50M commercialization of a medical device, to large cap pharmaceutical and bio- IPO of Addus HomeCare, a home which was successfully used in surgical tech companies . Key projects included healthcare provider . procedures with no adverse events . developing a formulary strategy for Created novel manufacturing process a small-molecule drug portfolio, JPMorgan Chase, New York, NY that significantly reduced number of conducting cost-sensitivity analysis Analyst, Diversified Industries Group, scrapped parts . for an anti-TNF biologic therapy and 2007-2009 analyzing drivers of market adoption Accumulated extensive modeling for an IV antibiotic . experience including LBOs, mergers, and equity and debt offerings . Ranked in top tier of analyst class and served as 1 of 2 Summer Program Leaders for 2008 summer intern class .

18 Amanda H. Li J. Yang Lin Nanxi Ling [email protected] [email protected] [email protected] Harvard University, Cambridge MA Georgia Institute of Technology, Atlanta, GA The University of Pennsylvania, A .B ., Cum Laude, Chemistry, 2009 B S. ., Highest Honor, Biomedical Engineering, Philadelphia, PA B S. ., Highest Honor, Economics, 2007 B .A ., Summa Cum Laude, International Relations, 2009 B .S ., Summa Cum Laude, Finance, 2009

An opportunity to analyze, invest and Impactful consulting or entrepreneurial An opportunity to develop and manage unlock value in healthcare innovation. opportunities where smart use of innovative, patient-centric products at a technology transforms patient experi- health care technology or services firm. Bank of America Merrill Lynch, ence and improves health outcome. New York, NY Sanofi, Bridgewater, NJ Summer Associate, Healthcare Investment Green Dot Public Schools, Diabetes Marketing MBA Intern, Banking, Summer 2013 Los Angeles, CA Summer 2013 Provided M&A advisory for life science Knowledge Management Extern, For a patient and physician support tools, diagnostics and life science com- Summer 2013 pilot, led the capture, analysis and pre- panies . Analyzed strategic acquisition Developed and launched an internal sentation of metrics to assess patient opportunities including redomiciling knowledge management portal for and physician engagement, scalability targets . Managed sell-side process and Green Dot’s most important functions and program design . Provided insights, developed management presentations (HR, Educator Effectiveness, New based on pilot, to design the full for specialty medical device company . Teacher Training, etc .) . Worked with program to maximize customer Performed valuation analyses using cross-functional team to established engagement and lower operational public comparables, precedent transac- best practices and protocol for codify- burden . Developed key leading and tions, and discounted cash flow . ing internal knowledge and sharing lagging indicators for a drug launch . within the internal portal via online AstraZeneca Pharmaceuticals, lesson format . Oliver Wyman, New York City, NY Waltham, MA Senior Consultant, 2011-2012 Business Development Associate, 2011-2012 Bain and Company, Atlanta, GA Consultant, Summer 2008, 2009-2011 Facilitated development and Consultant, 2008-2012 Advised health care and financial imple¬mentation of alliance and Contributed to over 10 Private Equity service firms on product launches, partnership with academic and biotech projects and 9 corporate clients across organizational optimization, and institutions . Negotiated, drafted and diverse industries . During my pre-MBA growth strategies . Sample projects executed agreements . Managed legal employment with Bain, I was pro- include: 1) created first Oliver Wyman compliance activities . moted to the post-MBA Consultant obstetrics patient care model for position due to strong performance . health insurer, along with business Associate Scientist, 2009-2011 Select cases include: 1) designing and requirements for pilot, with potential Designed, modeled and developed facilitating the launch of a client’s new impact on 60,000 women annually; antibacterial agents combating serious ultra-secure data hosting solutions for 2) developed resource optimization infections . Devised innovative healthcare providers; 2) IT non-labor strategies for health care analytics firm synthetic strategies delivering previ- sourcing strategy, Fortune 50 retailer, to improve operations and increase ously inaccessible targets . Co-authored estimated benefits of $50M+ annual scalability, with 10% potential cost 2 internal publications distributed savings from increased negotiation savings, 3) defined future-state organi- globally . Delivered high profile presen- leverage and reduced complexity; zational models for health insurer and tation on project portfolio and annual 3) Performance improvement, international bank, and 4) developed progress to 70-person department . Multinational Semiconductor Device multi-year roadmap and implementa- Facilitated management of overseas Manufacturer, estimated $35M+ sav- tion plan to build a bank division . technology contractors providing spe- ings and gross margin improvement . cific guidelines and analysis of work products and complicated data-sets . Chosen out of 200 global employees to receive AstraZeneca Infection Science & Innovation Award .

19 Lauren A. Matise, Matthew A. Ashwin R. Murthy [email protected] Ph.D. Mouradian University of California, Los Angeles, CA [email protected] matthew.mouradian.wg14@ B .S ., Physiological Science, 2007 Wake Forest University, Winston-Salem, NC wharton.upenn.edu B .S ,. Cum Laude with Honors in Biology, Yale College, New Haven, CT Biology, 2007 B A. ,. Cum Laude, with Distinction, History, Vanderbilt University School of Medicine, 2009 Nashville, TN Ph .D ., Summa Cum Laude, Cancer Biology, 2012

A commercial marketing opportunity in An opportunity to build, grow, or An opportunity to build and develop the pharmaceutical industry. improve organizations in the health successful healthcare businesses care industry. through an investing or strategy role. GlaxoSmithKline, Philadelphia, PA U.S. Pharmaceutical Summer MBA Intern, McKinsey & Company, Philadelphia, PA Bain & Company, Los Angeles, CA Marketing, Summer 2013 Summer Associate, Summer 2013 Summer Associate, Summer 2013 Directed and executed use of field en- Supported public sector client’s efforts Advised $15B industrial services client gagement platforms to garner market, to design and implement health care in optimizing operations and organi- customer, and field insights/feedback . payment innovation . Created opera- zational structure . Developed 3-prong Collaborated across matrixed teams tional and infrastructural plan for recommendation that increased to foster change management and assessment-based classification and throughput by 20%, standardized to improve organizational processes . treatment of highly complex patients . employee training and codified Analyzed regional performance activ- Devised exhaustive classification long-term business outlook . ity metrics relative to sales benchmarks system for medical claims to enable to identify brand strategy gaps . retrospective provider cost analysis . Centerview Partners LLC, Aggregated business unit and enter- San Francisco, CA prise project data to structure and The Advisory Board Company, Investment Banking Associate, 2011-2012 to maintain adherence to marketing Washington, DC Investment Banking Analyst, 2009-2011 visual controls . Senior Analyst, 2011-2012 Provided M&A advisory for biophar- Analyst, 2010-2011 maceutical and medical device clients . NextGxDx, Nashville, TN Associate, 2009-2010 Conducted extensive financial Product Development Analyst – Intern, 2012 Researched strategic issues for group analyses, developed multi-scenario Integrated scientific aspects of genetic of 200 non-hospital health care enti- valuation models and presented testing into genetic test ordering tech- ties including biopharmaceutical and recommendations to senior manage- nology platform . Analyzed, stream- medical technology manufacturers, ment teams . Key transaction lined, and beta-tested ordering information technology firms, and experience includes advising OSI technology interface by utilizing health plans . Authored (as lead or Pharmaceuticals in its $4B sale to physician/hospital feedback . contributor) approximately 40 strategy Astellas Pharmaceuticals, Haemonetics reports on topics such as hospital- in its $550M purchase of Pall Vanderbilt University School of supplier relations, payer-provider Corporation’s blood filtration devices Medicine, Laboratory of Harold Moses, relations, the medical home, and and Dendreon in its $125M divestiture M.D., Nashville, TN emerging provider reimbursement of Victrelis royalty assets to CPPIB . Ph.D. Candidate, 2007-2012 models . Presented on these topics to Used intravital imaging techniques to client audiences of up to 150, includ- Jefferies & Company, San Francisco, CA identify unique modes of cell migra- ing C-level executives . Developed Investment Banking Analyst, 2007 – 2009 tion that contribute to elevated levels Advisory Board’s product strategy for Advised healthcare services and bio- of breast cancer metastasis . Awarded two new market opportunities, en- pharmaceutical clients across a range a Department of Defense Pre-Doctoral couraging addition of sales staff and of transaction types . Focused primarily Breast Cancer Research Program guiding evolution of service offerings . on sell-side transactions to private eq- Fellowship, as well as an NIH uity sponsors . Key transaction experi- Microenvironmental Influences ence includes advising Covenant Care in Cancer Fellowship . Authored in its $200M sale to Centre Partners . 2 publications .

20 Masha Nikolski Yelena Ofengeym Andrew Z. Olian [email protected] [email protected] [email protected] Technion, Israel Institute of technology, New York University Stern School of Business Pomona College, Claremont, CA Haifa, Israel B S. ., Finance and Actuarial Science, 2007 B .A ., Cum Laude, Mathematical Economics B .A ., Computer Science, 2005 and International Relations, 2008 M .Sc ., Computer Science, 2010

An opportunity to apply technological An opportunity in strategy or business An opportunity to evaluate and build and business expertise in medical development at a healthcare company. successful healthcare businesses technology. through an investing or operational Bank of America Merrill Lynch, role. Docphin, New York, NY New York, New York General Management Intern, Summer 2013 Healthcare Investment Banking Intern, Abundant Venture Partners / AVIA, Defined and supervised implementa- Summer 2013 Chicago, IL tion of new Docphin Forum features Analyzed merger and acquisition Summer Associate, Summer 2013 based on feedback received from the opportunities within the healthcare in- Sourced investment opportunities, customers . Improved UI resulted in an dustry, including services, life sciences, independently led pitch meetings and increase in customer base . Evaluated managed care and medical device presented findings to investment com- competitive landscape of Continued sectors . Researched strategic rationale mittee . Worked directly with C-suite of Medical Education market, profiling and historical valuations for precedent AVIA (a healthcare start-up portfolio partnership opportunities . Presented transactions . Wrote company informa- company) to address strategic, tactical recommendations to the management tion memorandum, including invest- and financial issues . for future implementation . ment highlights and industry overview, which was distributed to the client’s The Center for Integrative Medicine, Biosense Webster, a J&J Company, executive management . New York, NY Yokneam, Israel Independent Consultant to CEO, Software Project Leader, 2010-2012 Stifel Nicolaus, New York, New York 2013-Present Software Engineer, 3D Expert, 2008-2010 Associate Analyst – Specialty Developed business plan and financial Led a team to deliver a newly devel- Pharmaceuticals Equity Research, 2010-2012 model and provided operational risk oped algorithm, added to CARTO3 Conducted in-depth company research assessment for CEO opening inte- Navigation System . Delivered first pro- focusing on detailed financial model- grated care clinics . Helping CEO secure totype before schedule, allowing early ing and valuation, qualitative research ~$4 .8M equity and ~$1 .6M debt . evaluation by select internationally (product lifecycle strategy, expense acclaimed physicians . Promoted the management) and macro driver Aurora Capital Group, Los Angeles, CA external evaluation of the system in analysis (reimbursement, prescription Associate, Private Equity Group, 2010-2012 hospitals over Europe and adapted the trends, healthcare reform) . Wrote and Identified and assessed platform and features based on physicians’ requests, published earnings previews and add-on investment opportunities resulting in customer demand to up- company coverage reports, reviewed within the healthcare services and IT grade the system to the new version clinical trial results and FDA releases, industries, among others . Led deal and increased sales . Received 2012 and analyzed competitive landscape, teams and negotiated purchase and 2010 “GM Award for Outstanding including prescription growth, pricing, credit agreements to execute M&A Work Performance, Biosense product positioning, market share and financing transactions . Monitored Webster” . changes and new drug launches . and supported portfolio companies as Interviewed consultants and manage- a Board observer; helped identify and Revolver, Animation & Game ment teams, attended physician and execute portfolio company strategic Technologies, Herzlia, Israel investor conferences . initiatives . Senior Software Engineer, 2007-2008 Developed cross platform polygon JP Morgan Asset Management, Goldman, Sachs & Co., San Francisco, CA graphics solutions for real-time render- New York, New York and Los Angeles, CA ing of 3D content in 2D environments . Research Associate – U.S. Equity Growth Investment Banking Analyst in Technology, Strategies, 2007-2010 Media & Telecommunications Group, Developed healthcare investment the- 2008-2010 ses and presented stock recommenda- Ranked in first tier of analyst class . tions to portfolio managers and senior research analysts .

21 Jaime Oriol Gopal P. Pai Mamta S. Patel [email protected] [email protected] [email protected] Comillas Pontificial University (I .C A. D. E. ),. University of Michigan, Ross School of Business, University of Michigan, Ross School of Business, Madrid, Spain Ann Arbor, MI Ann Arbor, MI B .A ., Business Administration, 2008 B B. .A ., Operations and Accounting, 2007 B .B .A ., with Distinction, University of Michigan Medical School, Operations Management and Business Ann Arbor, MI Information Technology, 2007 M D. . Candidate, 2014

Build an e-commerce business An opportunity to build a successful An opportunity in an entrepreneurial company that provides a wide range business within the health tech space, environment to drive change through of healthcare consumer products in gaining tangible operational experience. use of technology. Latin America. Ginger.io, San Francisco, CA Simplee, Palo Alto, CA Lentescol.co, Bogotá, Colombia Business Development and Clinical Advisor, Intern, B2B Marketing, Summer 2013 Co-founder, Summer 2013-Present Summer 2013 Implemented channel marketing strat- Launched LentesCol .co, an Performed a business line analysis to egy to drive inbound leads through e-commerce company that offers determine the most attractive medical educational and product webinars, ophthalmologic products in a simple, condition areas for the start-up attendance at conference exhibitions, fast and hassle-free way . Lentescol co. company to enter, resulting in the and creation of industry resources on delivers its products to the door of its company pursuing additional core Simplee website targeting provider clients at a great price . Managed the conditions . Managed key customer CFOs and Revenue Cycle Directors . operations and commercialization relationships, from deal initiation to Created strategic roadmap for educa- areas of the Company .Winners of the closure, crafting study designs and tional and product webinars . Managed TNW Colombia Startup Awards 2013 . grant proposals, as well as negotiating July webinar on provider point-of- IP rights . service collections doubling attendees Deloitte Corporate Finance, to 54 participants and generating 11 Madrid, Spain Bain & Company, Chicago, IL new sales leads . Provided direction to Associate, 2008-2012 Associated Consultant, 2007-2009 Sales and Implementation team mem- Managed the relationship and expec- Provided strategic and managerial bers on communication practices and tations with the client’s founders and guidance to companies across the expectation setting with prospective top management during the sale of a Health Care, Finance, Insurance and and existing clients to drive project leading international player special- Consumer Packaged Goods industries, and scope management . ized in active ingredients for the performing complex financial pharmaceutical and cosmetic industry modeling and managing executive Huron Healthcare, Chicago, IL to Lubrizol (Berkshire Inc . portfolio client relationships . Designed and Associate, Clinical Operations, 2010-2012 company) . Took an active role in the implemented an optimized physician Analyst, Clinical Operations, 2007-2010 relationship and negotiation with five compensation strategy based on a Consulted for health care providers international potential buyers while modified relative value unit system on clinical operations to assist facilities advising a leading Spanish Private leading to increased physician produc- in increasing capacity and reducing Equity on the sale of leading interna- tivity and identification of new hire average patient LOS . Managed teams tional player specialized in fine chemi- opportunities . of 2-15 in process redesign and to cals for the pharmaceutical industry implement technology solutions (€40 million) . Identified €10 million to streamline communication and potential synergies through the increase efficiency . Example projects construction of a multi-scenario include creating a centralized Patient business model while working Placement department, designing and alongside a Private Equity firm on implementing bedboards, and imple- the potential acquisition of specialized menting reporting tools to drive clinical chains in a build-up process change and sustain results . (€120 million) .

22 Diana F. Peng John Pettengill Lauren E. Post [email protected] [email protected] [email protected] Stanford University, Stanford, CA Rensselaer Polytechnic Institute, Troy, NY University of California Los Angeles, B .A ., Human Biology, 2009 B S. ., Mathematics, 2006 Los Angeles, CA B .A ., Sociology, 2009 B .A ., Economics, B .A ., Political Science, 2008

An opportunity with an entrepreneurial Seeking opportunities to research and An opportunity within an entrepreneur- team to build and develop innovative create new, patient centered products ial team that is using technology to Health IT products. and services to encourage better improve how providers deliver care. self-care. Castlight Health, San Francisco, CA CancerIQ, San Francisco, CA Product Management and Marketing Intern, Facebook, New York, NY Product Management & Summer 2013 Creative Social Media Strategy Intern, Business Development Intern, Collaborated with cross-functional Summer 2012 Summer 2013 – Present team of Engineering, Implementation Facilitated group brainstorms with Defined and designed new product and Business Development team CPG brands and their agencies around features and collaborated with team members to complete the initial brand voice and campaign messaging of overseas developers to execute launch of the multi-million dollar on Facebook . Collaborated directly finished product prototype . Created Pharmacy product . Oversaw analysis with creative agencies to create cam- original marketing and investor mate- of two external teams and determined paign materials that supported brand’s rials in preparation for RockHealth how to troubleshoot major product business objectives . investor pitch day . Provided feedback design challenges . Conducted a deep on business model and market oppor- dive on the Product Marketing support Razorfish, New York, NY tunity contributing to strategic shift . for the Mid-Market Sales team and the Associate Experience Director, Castlight Sales pitch . Helped revise June 2007-July 2012 RelayHealth, San Francisco, CA Sales training materials according to Created websites and mobile apps Product Management & Strategy Intern, findings and engaged senior Sales for large companies, including Pfizer, Summer 2013 leadership . Pearson and Morgan Stanley Smith Managed team of eight developers Barney . Mediated between a business’ through Kanban continuous develop- Bain and Company, San Francisco, CA objectives, the users’ needs and techni- ment process to develop new product Senior Associate Consultant, 2011-12 cal capabilities of various platforms . features . Recommended improve- Associate Consultant, 2009-2011 Led development of technical wire- ments to product maintenance pro- Completed 10+ cases for worldwide frames for digital products to detail cesses contributing to 80% decrease leaders in pharmaceuticals and their functionality . Led the research of customer issues . Built sensitivity technology . Advised multi-national and design of a patient-centered app analysis model to determine most technology leaders on hardware and for Type 2 Diabetics, presented find- significant drivers of product and software development process design, ings at South by Southwest Interactive customer profitability . product roadmap and human capital 2011 . management . Advised pharmaceutical Mercer Inc., clients on research process, sales strat- Los Angeles & San Francisco, CA egy and portfolio strategy . Examples: Associate, 2008-2012 1) Completed redesign of product Identified strategic improvements for development process for $120B semi- sales team effectiveness, including conductor producer, 2) Convinced organizational structure, territory Fortune 50 healthcare company to assignments, and sales incentive plans . double their medications packaging Measured alignment of executive capacity, 3) Completed in-depth compensation with company financial business case for innovative services results for technology clients . Directed business for global biotechnology cross-functional business development company . effort resulting in 3-year contract with academic medical center .

23 Andrew R. Ramish Jennifer F. Rizk Alcira Rodriguez [email protected] [email protected] Anton Stanford University, Stanford, CA Northwestern University, IL B .A ., with Distinction, International Relations, B A. ,. Political Science and Business Institutions, alcira.rodriguez.anton.wg14@ 2008 2009 wharton.upenn.edu University of Notre Dame, Notre Dame, IN B .S ., Mathematics, 2008

An opportunity to help transform the A strategic or operating role in A strategic opportunity within an US healthcare system through work healthcare services and technology. integrated hospital system or a leading with payers/providers or health IT children’s hospital. companies. Universal Health Services, King of Prussia, PA Intermountain Primary Children’s McKinsey & Company, Washington, DC Acute Care Intern, Summer 2013 Medical Center, Salt Lake City, UT Summer Associate, Summer 2013 Developed strategy and project plan Administrative Intern, Summer 2013 Worked with a state Medicaid agency for Physician Relationship Manage- Facilitated the development of a 5 to design and implement a new ment project including determining year strategic plan for rehabilitation payment model, which will motivate staffing needs, creating standardized services . Led the enhancement of the primary care doctors to better coordi- reporting mechanisms, orienting 50 rehabilitation department mission and nate care and control cost growth c-suite executives to plan and evaluat- vision . Developed an environmental while maintaining high quality . Aided ing CRM tool . Co-created marketing assessment for pediatric rehabilitation in creation of detailed rules and materials, physician presentations and in Utah . Conducted financial, volume, policies to guide doctors participating project plan for Clinical Integration in outcomes and demographic analyses in the program . Collaborated with order to enroll 2/3 of active medical to measure historical and current per- the client on strategy for creating a staff across 25 acute care facilities to formance . Outlined future challenges private sector market for care coordi- ultimately increase quality measures . and major aligned strategies for nation services in the state . Helped Performed cost comparison analysis rehabilitation services to focus on . determine the necessary IT systems on two diagnosis related groups at the to support the new payment model . acute care facilities in order to identify Deloitte Consulting LLP, Chicago, IL opportunities for clinical variation Consultant, 2010-2012; Analyst 2008-2010 The Avascent Group, Washington, DC reduction . Assessed the financial and workforce Consultant, 2010-2012 impact of healthcare reform on clients Senior Analyst, 2009-2010 Booz Allen Hamilton, McLean, VA operating across different industries . Analyst, 2008-2009 Senior Consultant, 2011-2012 Developed a comprehensive Total As Consultant, managed teams of 2-4 Consultant, 2009-2011 Rewards strategy for a hospital to analysts; created presentation message Managed team of 20 on a $40 million maintain the client’s long-term com- and structure . Acted as the primary two-year contract to implement petitive market positioning . Identified point of communication with the professional development programs over $6 .3M in health benefit plan client and the lead presenter in client to over 1,000 government employees . savings for a community hospital, all meetings . Focused on health IT and Conducted series of leadership inter- implemented by the client’s executive international development markets; views with government administrators team . Recognized a pharmacy knowl- completed 70 engagements, including to create advocacy for an insurance edge gap in our national staff; devel- more than 20 as engagement man- claims pilot project to evaluate effec- oped and led a training to address this ager, for clients ranging from Fortune tiveness of the claims processing opportunity . Managed consultants on 500 companies to major private equity facility; resulted in a 90% reduction the analysis of medical and pharmacy firms . in claims response time . Developed a bids, reported directly to senior leader- stakeholder engagement strategy that ship and frequently presented results included 2,000+ government employ- to clients . ees and top-level management .

24 Taylor B. Sewell Andrew Shelton Jiarui (Carrie) Shi [email protected] [email protected] [email protected] Vanderbilt University, Nashville, TN Tufts University, Medford, MA Fudan University, Shanghai, China B .S ,. Summa Cum Laude, Phi Beta Kappa, B A. ., Political Science, 2004 B .A ., Economics, 2008 Neuroscience, 2008 London School of Economics, London, UK Perelman School of Medicine at the University M Sc. ., Economics, 2008 of Pennsylvania, Philadelphia, PA M .D . Candidate, 2014

An opportunity to use my medical and An opportunity to help the healthcare An opportunity in strategy and business knowledge to improve clinical industry deliver better value for money. business development for a healthcare care in the face of a changing health organization. care landscape. McKinsey & Company, Atlanta, GA Summer Associate, Summer 2012 TrustBridge Partners, Shanghai, China Booz & Company, San Francisco CA Developed performance management Business Associate, Summer 2013 Summer Associate, Summer 2013 system for multi-billion dollar health- Analyzed market dynamic and Advised leading biotechnology client care client to track large-scale transfor- developed business strategy for the preparing for drug launch . Conducted mation across the organization . Women’s Health function of a tertiary primary and secondary research on Worked closely with internal stake- private hospital in Shanghai (a portfo- drug analogs to identify key launch holders to identify levers for cost lio company) . Successfully advised the considerations . Synthesized competi- reduction . C-level executives to adjust the space tive landscape information into design program based on the findings . comprehensive reference document . 2020 Delivery, London, UK Mobilized and cooperated with inter- Senior Consultant, 2009-2012 nal resource to push forward the Perelman School of Medicine, Worked at 10+ NHS care providers on research program . Philadelphia, PA a variety of engagements, including Clinical Research Coordinator, 2011-2012 development of clinical care pathways L.E.K. Consulting, Boston, Led health outcomes research study for a $1B health system and identifica- MA and Shanghai, China investigating effects of financial incen- tion of lost sources of revenue and Senior Associate Consultant, 2011-2012 tives on adherence . Managed daily inefficient pricing at a $1 .5B hospital . Associate Consultant, 2010-2011 operations, data analysis and manu- Role involved high degree of problem- Associate, 2008-2010 script writing . Increased study enroll- solving, client management and data Completed 15+ healthcare related ment 25% beyond initial goal by analysis . cases in both U .S . and China, ranging devising and managing patient from market entry, M&A evaluation, database . Oliver Wyman Financial Services, and healthcare policy analysis for vari- London, UK ous pharmaceutical and medical device United Community Clinics, Consultant, 2008-2009 clients . Led research programs and Philadelphia, PA Led analysis of compensation data built comprehensive models to under- Co-Coordinator, 2008-2009 from 30+ global banks during the stand the revenue and profit outlook, Oversaw acquisition of grant monies, financial crisis for joint OW/Institute competition landscape as well as sales volunteer scheduling and operations of International Finance report on and distribution efficiency . of this student-run health clinic . Led investment banking compensation . process analysis of staff workflow to identify and eliminate bottlenecks, The Advisory Board Company, increasing patient capacity 30% . Washington, DC Senior Analyst, 2005-2006 Journal of Clinical Anesthesia, Identified industry-leading practices Philadelphia, PA for two 100+ page reports on nurse Medical Manuscript Reviewer, Summer 2009 engagement and physician documen- Critiqued original manuscripts submit- tation for hospital billing . Co-authored ted for publication consideration in 4-page article published in Healthcare this medical journal . Evaluated meth- Financial Management Magazine, odology, internal consistency and June 2007 . accuracy .

25 Ross D. Stern Stephen D. Sweeny Geoffrey Tresley [email protected] [email protected] [email protected] Bowdoin College, Brunswick, ME Georgetown University, Washington, DC Northwestern University, Evanston, IL B .A ., Economics, 2007 B A. ,. Cum Laude, Political Economy B .A ., Summa Cum Laude, Economics, 2006 James Alton James Scholar (Highest Class GPA); Phi Beta Kappa (Junior 20)

An opportunity to build successful An opportunity to build healthcare com- An opportunity to build successful healthcare companies through panies through business development businesses and generate superior risk effective growth equity investment or entrepreneurial management. adjusted returns through healthcare- and management. focused investing. Medtronic, Jacksonville, FL Center for Medicare and Medicaid Business Development Intern, Summer 2013 Mount Kellett Capital Management, Innovation, Baltimore, MD Assisted Business Development Direc- New York, NY Summer Associate, Seamless Care Models tor in evaluating acquisition, invest- Summer Associate, Summer 2013 Group, Summer 2013 ment, in-licensing and divestiture Sole Summer Associate to receive Led in-depth return on investment opportunities in ENT and Neurosurgi- full-time offer since program inception analysis for six leading Accountable cal space . Activities included deal in 2009 . Evaluated debt and equity in- Care Organizations participating in the screening, market analysis, financial vestments across Healthcare, Consumer national Pioneer ACO Pilot Program . modeling, and contract review . Nota- / Retail, and FIG industries . Worked Presented analysis findings to ble deals included: divestiture of $11M extensively with CFO of portfolio Innovation Center leadership and business line; evaluation of OUS ENT company to restructure balance Pioneer ACO management teams to opportunity; assessment of potential sheet and address near-term liquidity help inform policy and operational $60M+ acquisition/investment . concerns . decisions related to population based payments, new program design, Amundsen Group, Burlington, MA Universal Health Services, scaling of shared savings programs Manager, 2010-2012 King of Prussia, PA and clinical intervention efficiency . Led start-up analytics business unit Summer Associate, Summer 2013 that developed and sold market access Helped design and implement Summit Partners, Boston, MA reporting tools to the Pharma indus- roll-out of new Physician Relationship Associate, Healthcare Private Equity, try . Grew business from concept to Management platform . Analyzed tuck- 2009-2012 revenue generation ($1 .4M, annually) in acquisition opportunities to bolster Originated and executed healthcare in less than one year, overseeing all care coordination efforts across UHS’ private equity investments, defined operations including product ideation, tertiary care facilities . strategic areas of interest, led financial product design, sales & marketing and analysis and due diligence processes client management . CVC Capital, New York, NY and worked with portfolio companies Associate, 2010-2012 on business development efforts . Senior Associate, 2007-2010 Received offer to forgo business Sourced four proprietary investments Worked on over 25 projects for school . Conducted extensive industry (Heart to Heart Hospice, MyDentist, Pharma and Biotech companies . and company-level due diligence to CrossFit and Covenant Surgical Responsibilities ranged from client analyze investment opportunities Partners) . Originated 16 Letters management to project management across Consumer/Retail, Healthcare, of Intent representing over $575M to heavy data analysis and modeling . and Industrial industries . Oversaw 2 of Summit Partners capital . Projects included: directing long range portfolio companies, monitoring planning process for $900M+ Biotech; performance and evaluating strategic Cowen and Company, New York, NY developing and leading integration of initiatives alongside management . Analyst, Healthcare Investment Banking, complex analytical model to support Selected Transaction Experience: $2 .8B 2007-2009 managed care contracting at top 3 Leveraged Buyout of BJ’s Wholesale Executed M&A and capital raising Pharma; design and implementation Club . transactions in the biotechnology, of co-pay assistance program for $4B+ pharmaceutical and medical device biologic . sectors .

26 Robert P. Varady Ryan Vass Elizabeth F. Weiss [email protected] [email protected] [email protected] Harvard College, Cambridge, MA University of Chicago, Chicago, IL Harvard College, Cambridge, MA A .B ., Cum Laude, Applied Mathematics, 2006 B A. ., Chemistry, 2007 A .B ., Magna Cum Laude With Highest Honors, Perelman School of Medicine at the University Psychology, 2009 of Pennsylvania, Philadelphia, PA M D. . Candidate, 2014

An opportunity in strategy for a health Entrepreneur interested in using An opportunity to pursue strategy or care services firm to leverage my data new types of patient-generated data business development with an innova- science background. to power learning health networks. tive team in the healthcare industry.

Deloitte Consulting, New York, NY Alloy Health Intelligence, Noom, New York, NY Summer Associate, Summer 2013 Philadelphia , PA MBA Intern, Strategy and Worked with a large health insurance Co-Founder and CEO, Summer 2013-Present Business Development, Summer 2013 company and a Deloitte-owned design Alloy helps hospitals build a more Designed and initiated plan to expand firm to estimate the financial impact interconnected healthcare delivery clinical presence and secure new of redesigning the customer experi- network . Hired by Children’s Hospital sources of revenue . Collaborated with ence, and to outline governance struc- of Philadelphia to help build the management, engineers and designers tures required for the transformation . National Pediatric Learning Health to execute development of new mo- System, which will bring together bile application for health and well- SAC Capital Advisors, Stamford, CT clinical, biospecimen, administrative ness . Assessed customer lifetime value Associate, Risk Management, 2010-2012 and patient-generated data of 2 .3 and retention . Evaluated historical Member of an 8-person global risk million children from eight leading financials and created models to management team overseeing risk children’s hospitals and three disease enable more informed operating and performance attribution of a $12B networks . Data will power rapid cycle and financing decisions . hedge fund . Generated performance quality improvement and comparative analytics, performed statistical effectiveness research . Initiated, J.P. Morgan, New York, NY modeling, and studied effectiveness negotiated, and closed data-sharing Senior Analyst, Healthcare Investment of different policies governing how deals with IMS Health and Optum Banking, 2011-2012 traders operate . Additionally created Labs . Helped architect patient Analyst, Healthcare Investment Banking, a new frame-work to evaluate informatics strategy . 2009-2011 traders’ ability to generate above- Worked on over 20 deals for market returns by observing minute- Global Development Collaborative, BioPharma, Pharma Services and by-minute alterations in trading Philadelphia, PA Health IT clients, including buy-side behavior . Founder and CEO, 2009-2012 and sell-side M&A, divestitures, joint Board member, 2012-Present ventures and equity/debt issuances . Goldman Sachs, New York, NY Non-profit startup improves the stan- Performed a variety of data and Associate, Quantitative Investment dard of living in developing countries financial analyses and managed due Strategies, 2006-2010 by more strategically leveraging their diligence processes for over 15 teams . Member of 13-person global equity existing capabilities . Developed self- Evaluated strategic alternatives for research team which developed, sustaining business model . Established Zoetis, which resulted in the largest tested, and implemented proprietary partnerships with health clinics, munic- carve-out IPO since 2007 ($3B) . Other strategies to trade $100B of global ipal governments, and international select transactions include Pfizer’s equity hedge fund and mutual fund NGOs . acquisition of King Pharmaceuticals accounts . Focus was on deriving ($4B), sale of Aptuit Clinical Trial actionable insights and predictive Center for Neurodegenerative Disease Supplies to Catalent ($410M) and analytics from an immense data Research, University of Pennsylvania, IPO of Greenway Medical ($77M) . warehouse containing structured Philadelphia, PA numerical data and unstructured text . Research Associate, 2009-2010 First author of paper published in Acta Neuropathologica, a top neuropathol- ogy journal . Coordinated collaboration of genomicists, neuropathologists, cognitive neuroscientists, and physi- cians .

27 Kevin P. Wu William B. Young Jackie Zider [email protected] [email protected] [email protected] Harvard College, Cambridge, MA University of Pennsylvania, Philadelphia, PA Princeton University, Princeton, NJ A .B ., Cum Laude, Government, 2005 B S. .E ,. Bioengineering, 2008 B .A ., Molecular Biology, 2006 B A. ,. Economics, 2008

An opportunity to work in strategy or An opportunity to build successful An opportunity to use my investing and corporate development for a medical healthcare businesses through an strategy experience to identify and help technology company. operational or strategic role. grow successful healthcare businesses.

Credit Suisse, New York, NY Bank of America Merrill Lynch McKesson Corporation, Summer Associate in Investment Banking, Summer Associate, Mergers & Acquisitions, San Francisco, CA Summer 2013 Summer 2013 Intern, Corporate Strategy and Advised clients in healthcare services, Performed M&A valuation analysis Business Development, Summer 2013 pharmaceutical, biotechnology, and (cost of capital analysis, DCF, compara- Investigated viability of independent medical devices industries . Performed ble transactions, etc .) on media, pharmacy customer base by quantify- financial analysis of leveraged buy- technology and industrial companies . ing impact of drivers such as outs, pro-forma merger consequences, Conducted buy-side and sell-side due exchanges, preferred pharmacy discounted cash flows and common diligence processes, developed presen- networks, and payer reimbursement stock comparisons . Created investor tation materials, managed Q&A pressure . Research resulted in ten year presentation and led valuation analysis process, organized diligence meetings, profitability forecast for the average for Community Health Systems’ buyout provided process updates to client, etc . independent pharmacy . Identified of Health Management Associates . areas to diversify revenue to mitigate Analyzed risks and trends in market The Chartis Group industry headwinds . growth of generic drug, pharmaceuti- Associate Consultant, 2010–2012 cal outsourcing and regenerative Analyst, 2008–2010 HarbourVest Partners, Boston, MA medicine industries . Implemented and identified opera- Senior Associate, 2011-2012 tional improvements and partnership Associate, 2009-2011 U.S. Army Special Forces opportunities to transform research Sourced, evaluated and monitored Special Forces Medic and Candidate, platform of an Academic Medical private equity investments primarily 2006-2012 Center . Designed new primary care in the healthcare and technology Trained and advised an elite unit of platform for a hospital resulting in sectors for a $35B private equity firm . 80 Guatemalan counterterrorism and better patient access and increased Executed initial and follow-on growth counternarcotics personnel . Provided satisfaction . Engaged management equity investment in Nexidia, a speech strategic military support to team and developed financial model analytics software company . Collabo- Guatemalan government in counter- to garner support for hospital to rated with CFO and VP of Sales to ing drug trafficking organizations . hospital acquisition resulting in a redefine sales pipeline methodology . Taught Guatemalan and Benin army successful merger and in significant Identified 20 new customer opportuni- medics on tactical combat casualty operational improvements . Led train- ties via the HarbourVest network . care . Trained in military, veterinary, ing and connectivity efforts for MBA / Proactively led sourcing effort for HIT dentistry, preventive, trauma, anesthe- MPH hires resulting in reduced companies by building relationships sia and clinical medicines . attrition rates . Restructured a cancer with CEOs and healthcare- institute to significantly reduce focused private equity investors . Booz Allen Hamilton cost structure and bring asset to Consultant, 2005-2006 profitability . Morgan Stanley, San Francisco, CA Analyzed industry supply chains for oil and New York, NY and gas control systems and enterprise Analyst, 2006-2009 storage devices and identified key Provided M&A, debt and equity trends . Drafted and submitted a financing advisory services to clients winning marketing proposal to hold in the consumer, retail, industrial and a conference on the use of web-based utility sectors . tools in enhancing organizational collaboration .

28 2013 Internship Sponsors

The following organizations DELOITTE CONSULTING MEDTRONIC DIABETES provided internships for Health Care New York, NY Los Angeles, CA Management Students in Summer, 2013. DOCPHIN MEDTRONIC 1DOCWAY New York, NY Jacksonville, FL New York, NY ESSEX WOODLANDS MISSIONPOINT HEALTH PARTNERS ABUNDANT VENTURE PARTNERS / AVIA Palo Alto, CA / New York, NY Nashville, TN Chicago, IL FACEBOOK MOUNT KELLER CAPITAL MANAGEMENT LP AIDIN New York, NY New York, NY New York, NY FERRER FREEMAN & COMPANY NOOM INC. ALLAZO HEALTH Greenwich, CT New York, NY New York, NY GAY & LESBIAN LATINO AIDS NOVARTIS AG ALLOY HEALTH INTELLIGENCE EDUCATION INITIATIVE Basel, Switzerland Philadelphia, PA Philadelphia, PA ONYX PHARMACEUTICALS AMERICAN SECURITIES GENENTECH South San Francisco, CA New York, NY South San Francisco, CA PFIZER ATHENAHEALTH GENERAL MILLS, INC. New York, NY Boston, MA Minneapolis, MN RA CAPITAL MANAGEMENT, LLC AVIA GINGER.IO Boston, MA Chicago, IL San Francisco, CA RELAYHEALTH BAIN & COMPANY GLAXOSMITHKLINE San Francisco, CA Los Angeles, CA Philadelphia, PA RXANTE BANK OF AMERICA MERRILL LYNCH GOLUB CAPITAL McLean, VA New York, NY Chicago, IL SANOFI BENEFITTER GREEN DOT PUBLIC SCHOOLS Bridgewater, NJ San Francisco, CA Los Angeles, CA SERATIS BOOZ & COMPANY GREENWAY MEDICAL TECHNOLOGIES Philadelphia, PA San Francisco, CA San Francisco, CA New York, NY SIMPLEE THE BEEKMAN GROUP LLC Palo Alto, CA New York, NY HOSPITAL OF THE UNIVERSITY OF PENN- SYLVANIA TELADOC THE BOSTON CONSULTING GROUP Philadelphia, PA Greenwich, CT San Francisco, CA Philadelphia, PA INTERMOUNTAIN PRIMARY CHILDREN’S TANGRAMCARE CORPORATION MEDICAL CENTER Irvine, CA CANCERIQ Salt Lake City, UT San Francisco, CA TRUSTBRIDGE PARTNERS JOHNSON & JOHNSON Shanghai, China CARLSON CAPITAL New Brunswick, NJ New York, NY UNIVERSAL HEALTH SERVICES KAISER PERMANENTE King of Prussia, PA CASTLIGHT HEALTH Oakland, CA San Francisco, CA VIKING GLOBAL LENTESCOL.CO New York, NY CENTER FOR MEDICARE & MEDICAID INNO- Bogotá, Colombia VATION Baltimore, MD MCKESSON CORPORATION San Francisco, CA CITIGROUP London, England MCKINSEY & COMPANY Washington, DC CLINTON HEALTH ACCESS INITIATIVE Atlanta, GA Pretoria, South Africa Summit, NJ Philadelphia, PA CREDIT SUISSE New York, NY

29 2013 Health Care Program Mentors

Mentors are leaders and senior managers GRANT BECHTOLD LUCAS BUCHANAN in the healthcare field who have agreed VP of Business Operations/Corporate Senior Director to provide career and professional Development Strategy and Corporate Development, Inc . development advice and guidance to Medsurant Holdings, LLC Impax Laboratories Health Care Management Students. (portfolio company New Capital Partners) Hayward, CA Denver, CO RICHARD CALIGARIS KEELY BECK ZIPP Int’l Business Leader / Launch Leader MICHAEL ABERMAN, MD Director, Franchise Operations, Oncology Roche Molecular Systems, Inc . Vice President, GlaxoSmithKline Pleasanton, CA Strategy and Investor Relations Collegeville, PA Regeneron Pharmaceuticals, Inc . DAVID CAMBOIA Tarrytown, NY ALI BEHBAHANI Director, Business Development Principal Sutter Health SANDIP AGARWALA New Enterprise Associates Modesto, CA Principal & Co-founder Washington, DC CrownWheel Partners, LLC NICOLE CARKNER New York, NY W. RYAN BERGER Executive Director Senior Business Analyst Quad City Health Initiative AMEYA AGGE Hearst Healthcare Innovations Davenport, IA Principal Los Angeles, CA Apax WILLIS CHANDLER New York, NY ALEXIS BERNSTEIN COO/EVP Director, Strategy & Operations, Shields Specialty Pharmacy SANJAY ANAND Accountable Care Solutions Worcester, MA President and CEO Aetna Option 1 Nutrition Boston, MA THIERRY CHAUCHÉ Chandler, AZ Director NIKHIL BHOJWANI Novartis Pharmaceuticals HEATHER ASPRAS Managing Partner East Hanover, NJ Brand Manager, MenHibrix Recon Strategy GlaxoSmithKline Cambridge, MA SARBANI CHAUDHURI Philadelphia, PA Head, Professional Strategies KERUN BINDRA and Business Development MEGAN AX Associate Director, Global Strategy US, Novartis Oncology Associate Director & Portfolio Strategy East Hanover, NJ Bristol-Myers Squibb AstraZeneca Princeton, NJ Vienna, VA GEORGE Z. CHEN, MD Chief Medical Officer DARSHAN BACHHAWAT ADAM BIRNBAUM BeiGene, Co . Strategic Sales Director Sales Strategy Sr . Manager Shanghai, China ZocDoc Medtronic New York, NY Minneapolis, MN MARK CHIN Senior Associate VIKRAM D. BAKHRU, MD DARREN BLACK Longitude Capital Chief Executive Officer Managing Director Menlo Park, CA Aspire Global Health Summit Partners Malvern, PA Boston, MA BRIAN G. CHOI, MD Associate Professor of Medicine & Radiology; JOHN BARKETT LISA BLUMSTEIN Co-Director, Advanced Cardiac Imaging Director, Vice President George Washington University Product Marketing and Policy Affairs TriNet Healthcare Consultant, Inc . Medical Faculty Associates Extend Health, Inc . Westford, MA Washington, DC San Mateo, CA STACEY BRENNER, MD EDUARDO CISNEROS ED BAXTER Medical Director Vice President, Business Development Managing Director – Regal Medical Group & DaVita Head of West Coast Life Sciences Lakeside Community Healthcare Chicago, IL Bank of America Merrill Lynch Northridge, CA San Francisco, CA RYAN COCHRAN DAVID BRILL, MD Associate MATTHEW BAYLEY, MD Principal, New Leaf Venture Partners Principal Corporate Development Associate New York, NY McKinsey & Company Medtronic Pittsburgh, PA Northridge, CA BRETT COHEN Vice President, Inpatient Services Fresenius Medical Care Waltham, MA

30 TERI CONDON PETER FISHMAN MARY HU Director, Analytic Offerings Founder Director, Institutional Planning IMS Health Inc . Tolograph and Communications Waltham, MA New York, NY Yale School of Medicine New Haven, CT MICHAEL CRAWFORD KATE J. FLYNN Manager, Health Industries Advisory President SEAN X. HU PwC (PricewaterhouseCoopers) Health Care Improvement Foundation Head, Bionest USA and Los Angeles, CA Philadelphia, PA Managing Partner North America, Bionest Partners STEVEN J. DAVIDSON, MD CHRIS FRANK Bionest Partners Senior Vice President and Partner, Life Sciences & Health Care New York, NY Chief Medical Informatics Officer Deloitte Consulting, LLP Maimonides Medical Center Parsippany, NJ TED HULL Brooklyn, NY Chairman, President and CEO BARRY R. FRANKEL Genova Diagnostics Inc . THIBAUT DE COURS Managing Director Asheville, NC Director of Strategy Frankel Group LLC 15 Healthcare New York, NY NOUHAD HUSSEINI London, UK Senior Director, Business Development MIHIR C. GANDHI Regeneron Pharmaceuticals SETH DEMAIN Director, Healthcare Venture Tarrytown, NY Analyst Investments SAC Capital AVIA Accelerator Innovation KEVIN JURKOWSKI New York, NY Chicago, IL Director, Program Management St . Jude Medical PITAMBER “PITOU” DEVGON, MD ONNE GANNEL Sylmar, CA Co-Founder / CEO Senior Director, Creative Vascular Strategy and Business Development DANIE KARP Philadelphia, PA Omnicell Senior Director, Mountain View, CA Worldwide Business Development BENJAMIN DORANZ Pfizer, Inc . President & Chief Scientific Officer MICHAL GATTNAR New York, NY Integral Molecular, Inc . Managing Director Philadelphia, PA Pavis Capital ADAM KAUFMAN Mill Valley, CA General Manager, Healthcare Solutions MOLLY DOYLE dLife Principal SIMEON J. GEORGE, MD Greenwich, CT Collaborative Healthcare Consulting Partner W . Newton, MA SR One FRAN KELLEHER San Francisco, CA Principal RAMI ELGHANDOUR BDC Advisors LLC Chief Business Officer AVIVAH GOLDMAN Silver Spring, MD Nevro National Quality Director Menlo Park, CA Aetna Health, Inc . RON C. KERO Blue Bell, PA Vice President, DANIEL FAGA Business Development & Operations Principal VIKAS GOYAL VHA West Coast Insurance & Centerview Partners Associate Financial Services San Francisco, CA SR One Renton, WA Cambridge, MA MING FANG DAVE KONCIAK Senior Associate JOACHIM M. GREUEL, PHD Principal Safeguard Scientifics Managing Director and Co-Founder Frankel Group Wayne, PA BioScience Valuation BSV GmbH New York, NY Grainau, Germany MICHAEL FAZEKAS JANE KRYMSKY Vice President JOHN HARRIS Product Manager Flexpoint Ford, LLC Principal Janssen Biotech, Johnson & Johnson Chicago, IL DGA Partners Horsham, PA Bala Cynwyd, PA EVAN FIELDSTON, MD RICHARD K. LEE, MD Assistant Professor of Pediatrics, BOSUN HAU Assistant Professor, Perelman School of Medicine; Partner Department of Urology Attending Physician General Pediatrics MVM Life Science Partners Weill Cornell Medical College Medical Director Care Model Innovation, Boston, MA New York, NY The Children’s Hospital of Philadelphia, Philadelphia, PA SAM HOLLIDAY JOHN LEWIS VP, Population Health Services Regional Vice President of Sales THOMAS J. (T.J.) FILIP Greenway Medical Technologies Athenahealth Dentist New York, NY Watertown, MA Garber Dental Bala Cynwyd, PA JARED P. HOPKINS Y. KAREN LI Director, Director, Global Pharma Strategy Strategic Finance and Business Consulting Novartis Pharma AG University of Michigan Health System Basel, Switzerland Ann Arbor, MI continued on next page

31 Health Care Program Mentors

MARK LYLES, MD WAYNE PAN, MD SHIVA SEKHAR Chief Strategic Officer Chief Medical Officer Director, Marketing Medical University of South Carolina Thrasys, Inc . Celgene Charleston, SC San Francisco, CA Mt . Laurel, NJ

ANKIT MAHADEVIA NEIL PARIKH DAVID SILK Principal Internal Medicine Resident Director, US Marketing, Atlas Venture Cedars Sinai, Los Angeles US Digital Acceleration Cambridge, MA Venice, CA Pfizer New York, NY BRYAN MARCOVICI LEN PODOLSKY Transformation Lead Director of Operations DANIEL A. SIMON Bridgewater Associates Connolly, LLC Director, Westport, CT Philadelphia, PA Corporate Strategy & Innovation Onyx Pharmaceuticals JEAN MELLETT DARSHAN PRABHU Stanford, CA Director of Planning Vice President/ Investment Banker Eastern Maine Healthcare System UBS Securities LLC / Global Healthcae ANNE SISSEL Brewer, ME Group Vice President New York, NY Dean Bradley Osborne KATHLEEN MEREDITH San Francisco, CA President KATE REED Tohder Consulting, Inc . Senior VP & Chief Strategy Officer JACK SLYE Frazer, PA Beth Israel Deaconess Medical Center Principal Boston, MA LLR Partners JUDITH MILLER JONES Philadelphia, PA Director JAMES F. RICHTER National Health Policy Forum President EBBEN SMITH Washington, DC CardioVIP Consultant Houston, TX McKinsey & Company REGAN MURPHY New York, NY Project Leader MATT RIEKE, MD Boston Consulting Co . Partner SPENCER SMITH Chicago, IL Quaker Partners Associate Philadelphia, PA Aisling Capital DAVID B. NASH, MD New York, NY Dean, Jefferson School of PAMELA RODMAN Population Health Administrator Director BHUVAN SRINIVASAN Thomas Jefferson University Columbia University Senior Associate Philadelphia, PA New York, NY Bain Capital Mumbai, INDIA TY NELSON FRED RONNAU EVP, Operations Senior Director JAMES STANFORD Health Carousel LLC Technology Strategy and Principal Cincinnati, OH Program Management Fitzroy Health McKesson Upper Montclair, NJ PRASHANT NIKAM San Francisco, CA Director – Global Commercial Leader, ANNA STERN Mozobil & Legacy Brands BENJAMIN ROOKS Medical Director Sanofi Managing Director Trillium Community Health Plans Cambridge, MA ST Advisors, Inc . Eugene, OR San Francisco, CA WESLEY NURSS WOLFGANG STOIBER, MD Associate DAVID SABLE, MD Co-Founder and Partner ISI Group Portfolio Manager, Life Sciences JSB Partners LP New York, NY Special Situations Funds Waltham, MA New York, NY JAMES O’CONNELL PATRICK SULLIVAN Principal and Kauffman Fellow ANYA SCHIESS Vice President Safeguard Scientifics Principal GMT Capital Wayne, PA Thomas, McNerney & Parnters New York, NY Stamford, CT JENNIFER O’NEILL ANTHONY SUN Brand Manager, Effient JAY SCHOMAKER Partner Daiichi Sankyo Inc . Director, Financial Planning & Analysis Aisling Capital Parsippany, NJ Cardinal Health New York, NY Dubin, OH JUSTIN PALLARI RUTH SUTER Assistant Administrator DAVID SCHUPPAN Senior Director, Market Access Intermountain Healthcare Partner and Patient Services Primary Children’s Med . Ctr . Cressey & Company LP BioMarin Pharmaceutical Salt Lake City, UT Chicago, IL Novato, CA

32 MARLON K. THOMPSON, PHD Senior Director, Strategic Planning Siemens Healthcare Diagnostics Administration Tarrytown, NY

MEAGAN UNTALAN Principal Advisory Board Company THOMAS S. ROBERTSON, PH.D. San Francisco, CA Dean, The Wharton School LISA VARSHNEY Associate Partner HOWARD KAUFOLD, PH.D. Rosetta Marketing Strategy & Insights Vice Dean and Director, New York, NY The Wharton Graduate Division

SHARON VOGEL LAWTON R. BURNS, PH.D., M.B.A. Director, Hospice Services Chair, BAYADA Home Health Care Health Care Management Department, The Wharton School; Philadelphia, PA Director, MBA Program in Health Care Management CHRISTOPHER VOJTA, MD CEO JUNE M. KINNEY, M.A. Upton Hill, LLC Associate Director, Edina, MN MBA Program in Health Care Management

LYNN WANG CHRISTINE ALESZCZYK Director, Financial Planning and Analytics Administrative Coordinator, WeightWatchers .com MBA Program in Health Care Management New York, NY JANICE SINGLETON ROBERT E. WATSON Administrative Coordinator, President and CEO MBA Program in Health Care Management Streamline Health, Inc . Atlanta, GA

TERRY WHITE, MD Physician Hawaii Permanente Medical Group Honolulu, HI

CHRIS WILKERSON President EquipSystems, LLC New York, NY

YAN XIONG Vice President, Pharmacy Strategy and Analytics Wellcare Health Plans Tampa, FL

DANIEL YIP Director, Business Operations Amicus Therapeutics Cranbury, NJ

ELLEN S. YOON Global Health Care Subject Matter Expert IBM Corp . New York, NY

WEI ZHANG, PHD Head, Corporate Development Good Start Genetics, Inc . Cambridge, MA

THOMAS ZIPP Global Brilinta Business Insight Lead, Brilinta AstraZeneca Pharmaceuticals Wilmington, DE

33 Faculty

The Program Faculty are drawn from EZEKIEL J. EMANUEL, M.D., PH.D. JUNE M. KINNEY, M.A. the Wharton School, the School of Diane v .S . Levy and Robert M . Associate Director, Graduate Program Levy University Professor and in Health Care Management; Medicine, the School of Nursing, and Vice Provost for Global Initiatives; Lecturer, Health Care Management, the School of Arts and Sciences at the Professor, Health Care Management, The Wharton School University of Pennsylvania and leading The Wharton School JONATHAN T. KOLSTAD, PH.D. health institutions in Philadelphia. ROBERT I. FIELD, J.D., PH.D., M.P.H. Assistant Professor, Health Care Additional support is provided by the Professor of Law at the Earle Mack School Management, The Wharton School of Law and Professor of Health Manage- Fellows and Associates of the Leonard ment and Policy at the School of Public GARY J. KURTZMAN, M.D. Davis Institute of Health Economics. Health at Drexel University, Philadelphia; Vice President, Life Sciences, Lecturer, Health Care Management, Safeguard Scientifics; Lecturer, The Wharton School Health Care Management, The Wharton School BRADLEY M. FLUEGEL EUGENIO ANESSI, PH.D. JEFFREY P. LIBSON, J.D. Senior VP & Chief Strategy Professor, Public Management, Partner, Pepper Hamilton LLP; Officer, Walgreens; Bocconi University Graduate School Lecturer, Health Care Management; Lecturer, Health Care Management, of Management, Milan, Italy; The Wharton School Lecturer and Senior Fellow, Health The Wharton School Care Management Department, HARI MAHADEVAN, PH.D. THOMAS N. GILMORE, M.ARCH. The Wharton School Independent Consultant; Vice President, Lecturer and Senior Fellow, The Center for Applied Research Inc .; DAVID A. ASCH, M.D., M.B.A. Health Care Management, Senior Fellow, Health Care Management, Executive Director, The Wharton School Penn Medicine Center for Health Care The Wharton School Innovation; STEVEN A. NICHTBERGER, M.D. JOHN P. GLASER, PH.D. Professor of Medicine, Adjunct Professor and Senior Fellow, Chief Executive Officer, Perelman School of Medicine Health Care Management, Health Systems Business Unit, Siemens; at the University of Pennsylvania; The Wharton School Lecturer, Health Care Management Professor, Health Care Management, The Wharton School The Wharton School MARK V. PAULY, PH.D. John M . and Thomas L . Bendheim HENRY A. GLICK, PH.D. LAWTON R. BURNS, PH.D., M.B.A. Professor; Professor, Health Care Professor of Medicine, Chair, Health Care Management Management, Business Economics and Perelman School of Medicine at Department, and Director, Public Policy, The Wharton School; the University of Pennsylvania; Health Care Management Program, Professor, Economics, College of Arts Professor, Health Care Management, The Wharton School, and Sciences The Wharton School James Joo-Jin Kim Professor WILLIAM P. PIERSKALLA, PH.D. of Health Care Management, MATTHEW R. GRENNAN PH.D. Professor Emeritus The Wharton School Assistant Professor, Faculty Co-Director, Health Care Management, DANIEL POLSKY, PH.D. Roy and Diana Vagelos Program The Wharton School Robert D . Eilers Professor of Health Care in Life Sciences & Management Management and Economics, SCOTT E. HARRINGTON, PH.D. The Wharton School; PATRICIA M. DANZON, PH.D. Alan B . Miller Professor of Health Care Professor of Medicine, Celia Z . Moh Professor of Health Care Management, and Insurance and Risk Perelman School of Medicine Management and Insurance and Risk Management, The Wharton School at the University of Pennsylvania; Management, The Wharton School Executive Director, Leonard Davis JOHN C. HERSHEY, PH.D. Institute of Health Economics GUY DAVID, PH.D. Anheuser-Busch Professor Emeritus Associate Professor, of Management Science; and DOUGLAS A. PRESENT, M.B.A. Health Care Management, Health Care Management, Independent Consultant; The Wharton School The Wharton School Lecturer, Health Care Management, The Wharton School BENJAMIN DORANZ, PH.D., M.B.A. NAOKI IKEGAMI, M.D. President and CSO, Integral Molecular, Professor, Keio University School of ARNOLD J. ROSOFF, J.D. Inc .; Senior Fellow, Health Care Medicine, Tokyo, Japan; Senior Fellow, Professor Emeritus, Legal Studies and Management, The Wharton School Health Care Management, Business Ethics; The Wharton School Lecturer, Health Care Management, MARK G. DUGGAN, PH.D. The Wharton School Professor, Business and Public Policy JOHN KIMBERLY, PH.D. and Health Care Management, Henry Bower Professor of Entrepreneurial STEPHEN M. SAMMUT The Wharton School Studies; Professor of Management, Venture Partner, Burrill & Company; Health Care Management, and Sociology, Lecturer and Senior Fellow, The Wharton School Health Care Management, Lecturer, Entrepreneurial Programs, The Wharton School

34 CYNTHIA SCALZI, M.N., PH.D. Professor Emeritus of Nursing and Health Care Management, The Wharton School

J. SANFORD SCHWARTZ, M.D. Leon Hess Professor in Internal Medicine, Perelman School of Medicine at the University of Pennsylvania; Professor, Health Care Management, The Wharton School

JEFFREY H. SILBER, M.D., PH.D. Director, Center for Outcomes Research, The Children’s Hospital of Philadelphia; Professor of Pediatrics and Anesthesiology & Critical Care, Perelman School of Medicine at the University of Pennsylvania; Professor, Health Care Management, The Wharton School

JEFFREY A. SOLOMON, M.D. Adjunct Associate Professor, Perelman School of Medicine at the University of Pennsylvania; Adjunct Associate Professor, Health Care Management, The Wharton School

AMANDA STARC, PH.D. The University of Pennsylvania Assistant Professor, values diversity and seeks talented Health Care Management, students, faculty and staff from diverse The Wharton School backgrounds . The University of Pennsylvania does not discriminate ASHLEY SWANSON, PH.D. on the basis of race, sex, sexual JUNE KINNEY Assistant Professor, orientation, gender identity, religion, Associate Director, Health Care Management, color, national or ethnic origin, age, MBA Program in The Wharton School disability, or status as a Vietnam Era Health Care Management Veteran or disabled veteran in the The Wharton School ROBERT J. TOWN, PH.D. administration of educational policies, Associate Professor, programs or activities; admissions Health Care Management policies; scholarship and loan awards; The Wharton School athletic, or other University adminis- tered programs or employment . KEVIN G.M. VOLPP, M.D., PH.D. Director, Center for Health Incentives Questions or complaints regarding and Behavioral Economics, this policy should be directed to: Leonard Davis Institute; Executive Director, Professor of Medicine, Office of Affirmative Action Perelman School of Medicine and Equal Opportunity Programs at the University of Pennsylvania; Sansom Place East Professor, Health Care Management, 3600 Chestnut Street, Suite 228 The Wharton School Philadelphia, PA 19104-6106 215 .898 .6993 (Voice) JOHN J. WHITMAN, M.B.A. 215 .898 .7803 (TDD) Executive Director, The TRECS Institute; Lecturer, Health Care Management, The Wharton School ©2004, The Trustees of the University of Pennsylvania . SANKEY V. WILLIAMS, M.D. All rights reserved . Sol Katz Professor of General Internal Medicine; Professor, LAWTON R. BURNS, PH.D., M.B.A. Health Care Management, Director, The Wharton School MBA Program in Health Care Management, Photography of Students: Stuart Watson The Wharton School Book Design: www.HollisterCreative.com

35 Wharton The Wharton School University of Pennsylvania

MBA Program in Health Care Management 3641 Locust Walk Philadelphia, PA 19104-6218

215 .898 .6861 fax 215 .573 .2157